- BGRY Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-1 Filing
Berkshire Grey (BGRY) S-1IPO registration
Filed: 20 Aug 21, 5:23pm
Delaware | 6770 | 85-2994421 | ||
(State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification Number) |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Title of each class of securities to be registered | Amount to be registered | Proposed maximum offering price per security | Proposed maximum aggregate offering price | Amount of registration fee | ||||||||||||
Class A common stock, par value $0.0001 per share | 205,457,460 | (1)(2) | $ | 8.48 | (3) | $ | 1,742,279,260.80 | $ | 190,082.67 | |||||||
Class A common stock par value $0.0001 per share | 14,750,000 | (4) | $ | 11.50 | (5) | $ | 169,625,000.00 | $ | 18,506.09 | |||||||
Warrants to purchase Class A common stock | 5,166,667 | (6) | — | — | — | (7) | ||||||||||
Total | $ | 208,588.75 | ||||||||||||||
(1) | Consists of (a) 183,207,460 shares of Class A common stock issued to certain selling securityholders in connection with the closing of the Business Combination (as defined herein), (b) 16,500,000 shares of Class A common stock issued to certain selling securityholders in private placements consummated in connection with the PIPE Investment (as defined herein) and (c) 5,750,000 shares of Class A common stock underlying the Class C common stock issued to certain selling securityholders in connection with the Initial Public Offering (as defined herein). |
(2) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement also covers any additional number of shares of Class A common stock issuable upon stock splits, stock dividends or other distribution, recapitalization or similar events with respect to the shares of Class A common stock being registered pursuant to this registration statement. |
(3) | Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, and based on the average of the high and low sales price per share of the registrant’s Class A common stock on The Nasdaq Stock Market LLC on August 17, 2021. |
(4) | Consists of (a) 5,166,667 shares of Class A common stock that may be issued upon the exercise of the Private Placement Warrants (as defined herein) and (b) 9,583,333 shares of Class A common stock that may be issued upon the exercise of the Public Warrants (as defined herein). |
(5) | Based upon the $11.50 exercise price per share of Class A common stock issuable upon exercise of the Private Placement Warrants and the Public Warrants. |
(6) | Represents the resale of the 5,166,667 Private Placement Warrants, which were issued on December 10, 2020 and will become exercisable upon effectiveness of this registration statement. |
(7) | In accordance with Rule 457(i) under the Securities Act, the entire registration fee for the Private Placement Warrants is allocated to the shares of Class A common stock issuable upon exercise of the Private Placement Warrants, and no separate fee is payable for the Private Placement Warrants. |
Page | ||||
ii | ||||
iii | ||||
iii | ||||
v | ||||
1 | ||||
6 | ||||
29 | ||||
30 | ||||
30 | ||||
31 | ||||
44 | ||||
58 | ||||
77 | ||||
82 | ||||
93 | ||||
96 | ||||
98 | ||||
104 | ||||
116 | ||||
117 | ||||
120 | ||||
121 | ||||
122 | ||||
F-1 |
• | “A&R Registration Rights Agreement” are to the Amended & Restated Registration Rights Agreement, dated as of July 21, 2021, by and among the Company, RAAC Management LLC, Steven A. Museles, Phyllis R. Caldwell, Jason M. Fish, Andrew Wallace and certain former stockholders of Legacy Berkshire Grey. |
• | “Berkshire Grey” are to Berkshire Grey, Inc., (f/k/a Revolution Acceleration Acquisition Corp), a Delaware corporation, and its consolidated subsidiaries after the effective time of the Merger Agreement. |
• | “Business Combination” are to the business combination between RAAC and Berkshire Grey pursuant to the terms of the Merger Agreement. |
• | “Bylaws” are to the amended and restated bylaws of Berkshire Grey. |
• | “Charter” are to the third amended and restated certificate of incorporation of Berkshire Grey. |
• | “Closing” are to the consummation of the Business Combination. |
• | “COVID-19” are toSARS-CoV-2 COVID-19, and any evolutions, mutations or variants thereof or related to associated epidemics, pandemics or disease outbreaks. |
• | “Exchange Act” are to the Securities Exchange Act of 1934, as amended. |
• | “GAAP” are to generally accepted accounting principles in the United States as in effect from time to time. |
• | “Initial Public Offering” means the initial public offering of RAAC, that was completed on December 10, 2020, of 28,750,000 RAAC Units. |
• | “Internal Revenue Code” are the Internal Revenue Code of 1986, as amended. |
• | “Merger Agreement” are to the Agreement and Plan of Merger, dated as of February 23, 2021, by and among RAAC, Merger Sub and Berkshire Grey. |
• | “Merger Sub” are to Pickup Merger Corp, a Delaware corporation. |
• | “Nasdaq” are to The Nasdaq Stock Market LLC. |
• | “PIPE Investment” are to the purchase of 16,500,000 shares of Class A common stock pursuant to the Subscription Agreements. |
• | “RAAC” are to Revolution Acceleration Acquisition Corp, a Delaware corporation, prior to the effective time of the Merger Agreement. |
• | “Private Placement Warrants” are to the 5,166,667 redeemable warrants of the Company that were sold in a private placement to the Sponsor concurrently with RAAC’s initial public offering at a purchase price of $1.50 per warrant. The Private Placement Warrants are identical to the Public Warrants except that, as long as the Sponsor or its permitted transferees beneficially own the Private Placement Warrants, the Private Placement Warrants (including the shares of Class A common stock issuable upon exercise of such Private Placement Warrants) are subject to certain transfer restrictions and the holders thereof are entitled to certain registration rights, and: (1) will not be redeemable by the Company (except as described under “ Description of Securities—Warrants |
• | “Public Warrants” are to the 9,583,333 redeemable warrants of the Company sold as part of the RAAC Units in RAAC’s initial public offering. Each whole Public Warrant entitles the holder thereof to purchase one share of Class A common stock for $11.50 per share, subject to adjustment and in accordance with the terms of the Public Warrants. |
• | “RAAC Units” are to the units of RAAC sold in connection with RAAC’s initial public offering, each such unit consisting of one share of Class A common stock and one-third of one Public Warrant. |
• | “SEC” are to the United States Securities and Exchange Commission. |
• | “Securities Act” are to the Securities Act of 1933, as amended. |
• | “Sponsor” are to RAAC Management LLC, a Delaware limited liability company and the sponsor of RAAC. |
• | “Subscription Agreements” are to the subscription agreements, entered into as of February 23, 2021, by and between RAAC and the PIPE Investors, pursuant to which the PIPE Investment will be consummated. |
• | the expected benefits from the Business Combination; |
• | Berkshire Grey’s plans to develop and commercialize its product candidates; |
• | Berkshire Grey’s ability to continue to develop new innovations to meet constantly evolving customer demands; |
• | Berkshire Grey’s expectations regarding the impact of the ongoing COVID-19 pandemic on its business, industry and the economy; |
• | Berkshire Grey’s estimates regarding future expenses, revenue, earnings, margin, capital requirements and needs for additional financing after the Business Combination; |
• | Berkshire Grey’s expectations regarding the growth of its business, including the potential size of the total addressable market; |
• | Berkshire Grey’s ability to maintain and establish collaborations or obtain additional funding; |
• | Berkshire Grey’s ability, subsequent to the consummation of the PIPE Investment and the Business Combination, to obtain funding for its future operations and working capital requirements and expectations regarding the sufficiency of its capital resources; |
• | the implementation of Berkshire Grey’s business model and strategic plans for its business following the Business Combination; |
• | Berkshire Grey’s intellectual property position and the duration of its patent rights; |
• | developments or disputes concerning Berkshire Grey’s intellectual property or other proprietary rights; |
• | Berkshire Grey’s ability to compete in the markets it serves; |
• | Berkshire Grey’s expectations regarding its entry into new markets; |
• | competition in Berkshire Grey’s industry, the advantages of Berkshire Grey’s solutions and technology over competing products and technology existing in the market and competitive factors including with respect to technological capabilities, cost and scalability; |
• | the impact of government laws and regulations and liabilities thereunder; |
• | Berkshire Grey’s need to hire additional personnel and our ability to attract and retain such personnel; |
• | Berkshire Grey’s ability to raise financing in the future; and |
• | the anticipated use of Berkshire Grey’s cash and cash equivalents. |
• | We have incurred net losses in every year since our inception, we anticipate expenses will increase in the future and we may not be able to achieve or maintain profitability in the future. |
• | We have generated substantially all of our revenue to date, and expect to generate a significant portion of our future revenue, from a limited number of customers. |
• | We have generated substantially all of our revenue to date from three product solutions. |
• | Our mobile solutions use lithium-ion battery cells, which have been observed to catch fire or vent smoke and flame in limited circumstances, and such events have raised concerns, and future events may lead to additional concerns, about the batteries we use, which could have a negative impact on our sales or our reputation. |
• | Our sales channels are currently limited, and our business may not grow as rapidly as we expect if we do not successfully develop other sales channels such as business partnerships and strategic alliances. |
• | If our suppliers or other third-party vendors become unavailable or produce inadequate supplies or services, we may be unable to obtain necessary hardware, software and operational support, and our customer relationships, results of operations and financial condition may be adversely affected. |
• | The facilities of our third-party contract manufacturers, our suppliers and our customers are vulnerable to disruption due to natural or other disasters, strikes, pandemics (including COVID-19) and other events beyond our control. |
• | Our existing and planned global operations subject us to a variety of risks and uncertainties that could adversely affect our business and operating results. Our business is subject to risks associated with selling our solutions in locations outside the United States. |
• | We may face liability if our solutions are used by our customers to handle dangerous materials. |
• | Global economic, political and social conditions and uncertainties in the markets that we serve, including risks and uncertainties caused by the COVID-19 pandemic, may adversely impact our business. |
• | Third parties may claim that our solutions or services infringe or otherwise violate their proprietary rights, which claims and any related litigation may adversely affect our business, financial condition and results of operations. |
• | If we cannot cost-effectively develop proprietary technology, content, branding or business methods, or license them on favorable terms, we may be unable to compete effectively or to operate our business in certain jurisdictions. |
• | Litigation or investigations involving us could result in material settlements, fines or penalties and may adversely affect our business, financial condition and results of operations. |
• | We may require additional capital to support business growth, and this capital may not be available on acceptable terms, if at all. |
• | As part of our growth strategy, we expect to acquire or make investments in other businesses, patents, technologies, products or services. Our failure to do so successfully could disrupt our business and have an adverse impact on our financial condition. |
• | Our decision to expand existing solutions offerings into new markets or to launch new solutions may consume significant financial and other resources and may not achieve the desired results. |
• | We have a broad range of competitors, including automation and robotics suppliers, more diversified technology providers and providers of alternative products, which could adversely impact the price of our solutions and our ability to increase our market share. |
• | Our failure to meet our customers’ price expectations or declines in the prices of our solutions and services or in our sales volume would adversely affect our business and results of operations. |
• | We may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless. |
• | Berkshire Grey’s operations may be materially adversely affected by the COVID-19 pandemic. |
• | Our warrants are accounted for as liabilities and the changes in value of our warrants could have a material effect on our financial results. |
• | In connection with the Business Combination, we have identified a material weaknesses in our internal control over financial reporting as of December 31, 2020 and March 31, 2021. If we are unable to develop and maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business and operating results. |
• | We may face litigation and other risks and uncertainties as a result of the material weaknesses in our internal control over financial reporting and the restatement of our financial statements. |
• | We do not intend to pay dividends on our common stock for the foreseeable future. |
• | If securities analysts do not publish research or reports about us, or if they issue unfavorable commentary about us or our industry or downgrade our common stock, the price of our common stock and warrants could decline. |
• | Our issuance of additional shares of common stock or convertible securities could make it difficult for another company to acquire us, may dilute your ownership of us and could adversely affect the price of our stock and warrants. |
• | Future sales, or the perception of future sales, of our common stock or securities convertible into our common stock by us or our existing stockholders in the public market could cause the market price for our common stock and warrants to decline. |
• | Certain provisions, including anti-takeover provisions, in Berkshire Grey’s governing documents and under Delaware law could make an acquisition of us more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our common stock and warrants. |
• | Berkshire Grey’s Bylaws designate the Court of Chancery of the State of Delaware as the sole and exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or other employees. |
Class A common stock offered by the Selling Securityholders | 205,457,460 shares |
Class A common stock offered by us | 14,750,000 shares issuable upon the exercise of the warrants |
Warrants offered by the Selling Securityholders | 5,166,667 Private Placement Warrants |
Exercise Price of warrants | $11.50 per share, subject to adjustment as described herein |
Use of proceeds | We will not receive any proceeds from the sale of shares or warrants by the selling securityholders. We will receive the proceeds from any exercise of the warrants for cash, which we intend to use for general corporate and working capital purposes. |
Risk factors | You should carefully read the “Risk Factors” beginning on page 6 and the other information included in this prospectus for a discussion of factors you should consider carefully before deciding to invest in our Class A common stock and warrants. |
Nasdaq symbol for our Class A common stock | “BGRY” |
Nasdaq symbol for our warrants | “BGRYW” |
• | unpredictable and unexpected increases in manufacturing and repair costs; |
• | inability to control the quality and reliability of finished solutions; |
• | inability to control delivery schedules; |
• | potential liability for expenses incurred by third-party contract manufacturers in reliance on our forecasts that later prove to be inaccurate; |
• | potential lack of adequate capacity to manufacture all or a part of the solutions we require; |
• | potential high switching costs in the event our relationship with a manufacturer ceases; |
• | potential liability to customers for delays in delivery caused by dependence on third-party manufacturers to provide components; and |
• | potential labor unrest affecting the ability of the third-party manufacturers to produce our solutions. |
• | difficulties in staffing and managing foreign operations; |
• | limited protection for the enforcement of contract and intellectual property rights in certain countries where we may sell our solutions or work with suppliers or other third parties; |
• | potentially longer sales and payment cycles and potentially greater difficulties in collecting accounts receivable; |
• | costs and difficulties of customizing solutions for foreign countries; |
• | challenges in providing solutions across a significant distance, in different languages and among different cultures; |
• | laws and business practices favoring local competition; |
• | being subject to a wide variety of complex foreign laws, treaties and regulations and adjusting to any unexpected changes in such laws, treaties and regulations; |
• | specific and significant regulations, including, but not limited to, the European Union’s General Data Protection Regulation (“GDPR”), which imposes compliance obligations on companies who possess and use data of EU residents; |
• | differences in analysis of regulatory, legal and tax issues across various countries, such as different interpretations of antitrust and competition laws; |
• | uncertainty and resultant political, financial and market instability arising from the United Kingdom’s exit from the European Union; |
• | compliance with U.S. laws affecting activities of U.S. companies abroad, including the U.S. Foreign Corrupt Practices Act; |
• | uncertainties related to geopolitical risks, including the relationship between the U.S. government and the government of other nations; |
• | tariffs, trade barriers and other regulatory or contractual limitations on our ability to sell or develop our solutions in certain foreign markets; |
• | operating in countries with a higher incidence of corruption and fraudulent business practices; |
• | changes in regulatory requirements, including export controls, tariffs and embargoes, other trade restrictions, competition, corporate practices and data privacy concerns; |
• | potential adverse tax consequences arising from global operations; |
• | seasonal reductions in business activity in certain parts of the world, particularly during the summer months in Europe and at year-end globally; |
• | rapid changes in government, economic and political policies and conditions; and |
• | political or civil unrest or instability, terrorism or epidemics or pandemics (including any risks related to or resulting from COVID-19) and other similar outbreaks or events. |
• | develop cost-effective new solutions and technologies that address the increasingly complex needs of prospective customers in a cost-effective manner or at all; |
• | enhance our existing solutions and technologies; |
• | respond to technological advances and emerging industry standards and certifications on a cost-effective and timely basis; |
• | adequately protect our intellectual property as we develop new solutions and technologies; |
• | identify the appropriate technology or product to which to devote our resources; or |
• | ensure the availability of cash resources to fund research and development. |
• | diversion of management’s attention from their day-to-day |
• | unanticipated or significant costs or liabilities associated with the acquisition; |
• | incurrence of acquisition-related costs, which would be recognized as a current period expense; |
• | problems integrating the purchased business, products or technologies; |
• | challenges in achieving strategic objectives, cost savings and other anticipated benefits; |
• | inability to maintain relationships with key customers, suppliers, vendors and other third parties on which the purchased business relies; |
• | the difficulty of incorporating acquired technology and rights into our platform and of maintaining quality and security standards consistent with our brand; |
• | difficulty in maintaining controls (financial or otherwise), procedures and policies during the transition and integration; |
• | material changes to our business or product offerings resulting from regulatory compliance; |
• | challenges in integrating the new workforce and the potential loss of key employees, particularly those of the acquired business; and |
• | use of substantial portions of our available cash or the incurrence of debt to consummate the acquisition. |
• | the previous and continued impact of the COVID-19 pandemic on our financial condition and the results of operations; |
• | our operating and financial performance and prospects; |
• | our quarterly or annual earnings or those of other companies in our industry compared to market expectations; |
• | conditions that impact demand for our solutions; |
• | future announcements concerning our business, our clients’ businesses or our competitors’ businesses; |
• | the public’s reaction to our press releases, other public announcements and filings with the SEC; |
• | the market’s reaction to our reduced disclosure and other requirements as a result of being an “emerging growth company” under the Jumpstart Our Business Startups Act (the “JOBS Act”); |
• | the size of our public float; |
• | coverage by or changes in financial estimates by securities analysts or failure to meet their expectations; |
• | market and industry perception of our success, or lack thereof, in pursuing our growth strategy and the effects of such perception on our brand and reputation; |
• | strategic actions by us or our competitors, such as acquisitions or restructurings; |
• | changes in laws or regulations which adversely affect our industry or us; |
• | changes in accounting standards, policies, guidance, interpretations or principles; |
• | changes in senior management or key personnel; |
• | issuances, exchanges or sales, or expected issuances, exchanges or sales of our capital stock; |
• | adverse resolution of new or pending litigation against us; and |
• | changes in general market, economic and political conditions in the United States and global economies or financial markets, including those resulting from natural disasters, terrorist attacks, acts of war and responses to such events. |
• | a staggered board, which means that our board of directors is classified into three classes of directors with staggered three-year terms and directors may be removed from office (i) only for cause and (ii) only by the affirmative vote of the holders of not less than two thirds of the outstanding shares of capital stock then entitled to vote at an election of directors; |
• | limitations regarding special stockholder meetings, including the requirement that a special meeting of stockholders may be called only by a majority of the entire Berkshire Grey board of directors, which could delay the ability of stockholders to force consideration of a proposal or to action, including the removal of directors and the adoption of desired governance changes; |
• | a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of stockholders and, therefore, could delay the ability of stockholders to force consideration of a stockholder proposal or to take action; |
• | the authorization of undesignated preferred stock, the terms of which may be established and shares of which may be issued without further action by our stockholders; |
• | the ability of the Berkshire Grey board of directors to amend its Bylaws, which may allow the Berkshire Grey board of directors to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend the Bylaws to facilitate an unsolicited takeover attempt; |
• | limitation of liability of, and the indemnification of, Berkshire Grey’s directors and officers; and |
• | advance notice procedures, which apply for stockholders to nominate candidates for election as directors or to bring matters before an annual meeting of stockholders. |
• | Berkshire Grey’s stockholders will have a majority of the voting power; |
• | The majority of the members of the existing board of directors of Berkshire Grey will comprise the majority of the members of the Combined Company Board; |
• | Berkshire Grey’s existing management will comprise the management of the Combined Company; |
• | Berkshire Grey will comprise the ongoing operations of the Combined Company; |
• | Berkshire Grey is the larger entity based on historical revenues and business operations; and |
• | Combined Company will assume Berkshire Grey’s name. |
(in thousands) | Purchase price | Shares Issued | ||||||
Share Consideration to Berkshire Grey (a)(b) | $ | 2,250,000 | 225,000 | |||||
(a) | The value of Class A common stock issued to Berkshire Grey included in the consideration is reflected at $10.00 per share as defined in the Merger Agreement. |
(b) | The total 225.0 million consideration shares include approximately 196.8 million shares to be issued for all issued and outstanding Berkshire Grey common and preferred stock plus approximately 28.2 million shares underlying unvested and/or unexercised restricted stock and options. |
Shares | % | |||||||
RAAC Public Stockholders | 5,498 | 2.4 | % | |||||
RAAC Sponsor and Directors | 9,583 | 4.2 | % | |||||
Total RAAC | 15,081 | 6.6 | % | |||||
Berkshire Grey (a) | 196,766 | 86.2 | % | |||||
PIPE Shares | 16,500 | 7.2 | % | |||||
Total Shares at Closing (excluding certain Berkshire Grey shares) | 228,347 | 100 | % | |||||
Berkshire Grey-Remaining Consideration Shares (a) | 28,234 | |||||||
Total Shares at Closing (including certain Berkshire Grey shares) | 256,581 | |||||||
(a) | Total consideration to be issued to Berkshire Grey is $2.25 billion or 225.0 million shares ($10.00 per share price). The total shares to be issued includes Berkshire Grey common and preferred stock plus shares |
underlying unvested and/or unexercised restricted stock and stock options. Accordingly, the consideration shares outstanding at the closing of the Business Combination has been adjusted to exclude the portion of consideration shares that will be attributed to unvested, and/or unexercised share awards at the closing of the Business Combination. |
RAAC Historical | RAAC Pro Forma Adjustments | Note 3 | RAAC As Adjusted | |||||||||||||
ASSETS | ||||||||||||||||
CURRENT ASSETS | ||||||||||||||||
Cash and cash equivalents | $ | 124 | $ | 41,193 | (A) | $ | 41,317 | |||||||||
Accounts receivable | — | — | — | |||||||||||||
Inventories | — | — | — | |||||||||||||
Deferred fulfillment costs | — | — | — | |||||||||||||
Prepaid expenses | 365 | — | 365 | |||||||||||||
Deferred transaction costs | ||||||||||||||||
Other current assets | — | — | — | |||||||||||||
Total current assets | 489 | 41,193 | 41,682 | |||||||||||||
Property and equipment - net | — | — | — | |||||||||||||
Restricted cash | — | — | — | |||||||||||||
Cash held in trust account | 287,539 | (287,539 | ) | (B) | — | |||||||||||
Other non-current assets | — | — | — | |||||||||||||
Total Assets | $ | 288,028 | $ | (246,346 | ) | $ | 41,682 | |||||||||
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ | ||||||||||||||||
CURRENT LIABILITIES | ||||||||||||||||
Accounts payable | $ | — | $ | — | $ | — | ||||||||||
Accrued expenses | 3,053 | — | 3,053 | |||||||||||||
Contract liabilities | — | — | — | |||||||||||||
Promisory Note - related party | 500 | — | 500 | |||||||||||||
Other current liabilities | — | — | — | |||||||||||||
Total current liabilities | 3,553 | — | 3,553 | |||||||||||||
Deferred underwriting fee payable | 10,063 | (10,063 | ) | (C) | — | |||||||||||
Warrant liability | 29,603 | — | 29,603 | |||||||||||||
Share-based compensation liability | — | — | — | |||||||||||||
Other non-current liabilities | — | — | — | |||||||||||||
Total Liabilities | 43,219 | (10,063 | ) | 33,156 | ||||||||||||
MEZZANINE EQUITY | ||||||||||||||||
Redeemable convertible preferred stock | — | — | — | |||||||||||||
Class A common stock subject to redemption | 287,500 | (287,500 | ) | (D) | — | |||||||||||
STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||
Class A common stock | — | — | — | |||||||||||||
Class B common stock | — | — | — | |||||||||||||
Class C common stock | 1 | — | 1 | |||||||||||||
Common stock | — | 1 | (D) | 1 | ||||||||||||
Additional paid-in capital | 24 | 51,216 | (D) | 51,240 | ||||||||||||
Accumulated deficit | (42,716 | ) | — | (42,716 | ) | |||||||||||
Accumulated other comprehensive income | — | — | — | |||||||||||||
Total stockholders’ equity (deficit) | (42,691 | ) | 51,217 | 8,526 | ||||||||||||
Total liabilities and stockholders’ equity (deficit) | $ | 288,028 | $ | (246,346 | ) | $ | 41,682 | |||||||||
Berkshire Grey Historical | Berkshire Grey Pro Forma Adjustments | Note 3 | Berkshire Grey As Adjusted | |||||||||||
ASSETS | ||||||||||||||
CURRENT ASSETS | ||||||||||||||
Cash and cash equivalents | $ | 52,830 | $ | (2,200 | ) | (E) | $ | 50,630 | ||||||
Accounts receivable | 2,669 | — | 2,669 | |||||||||||
Inventories | 2,719 | — | 2,719 | |||||||||||
Deferred fulfillment costs | 13,373 | — | 13,373 | |||||||||||
Prepaid expenses | 2,537 | — | 2,537 | |||||||||||
Other current assets | 2,091 | — | 2,091 | |||||||||||
Total current assets | 76,219 | (2,200 | ) | 74,019 | ||||||||||
Property and equipment - net | 10,466 | — | 10,466 | |||||||||||
Restricted cash | 1,121 | — | 1,121 | |||||||||||
Cash held in trust account | — | — | — | |||||||||||
Deferred transaction costs | 1,770 | (1,770 | ) | — | ||||||||||
Other non-current assets | 24 | — | 24 | |||||||||||
Total Assets | $ | 89,600 | $ | (3,970 | ) | $ | 85,630 | |||||||
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT | ||||||||||||||
CURRENT LIABILITIES | ||||||||||||||
Accounts payable | $ | 5,412 | $ | — | $ | 5,412 | ||||||||
Accrued expenses | 12,339 | (1,770 | ) | 10,569 | ||||||||||
Contract liabilities | 23,765 | — | 23,765 | |||||||||||
Other current liabilities | 181 | — | 181 | |||||||||||
Total current liabilities | 41,697 | (1,770 | ) | 39,927 | ||||||||||
Deferred underwriting fee payable | — | — | — | |||||||||||
Warrant liability | — | — | ||||||||||||
Share-based compensation liability | 21,371 | (3,158 | ) | (F) | 18,213 | |||||||||
Other non-current liabilities | 1,996 | 1,996 | ||||||||||||
Total Liabilities | 65,064 | (4,928 | ) | 60,136 | ||||||||||
MEZZANINE EQUITY | ||||||||||||||
Redeemable convertible preferred stock | 223,442 | (223,442 | ) | (G) | — | |||||||||
Class A common stock subject to redemption | — | — | — | |||||||||||
STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||
Class A common stock | — | — | — | |||||||||||
Class B common stock | — | — | — | |||||||||||
Class C common stock | — | — | — | |||||||||||
Common stock | 3 | 17 | (G) | 20 | ||||||||||
Additional paid-in capital | 29,237 | 224,383 | (E), (F), (G) | 253,620 | ||||||||||
Accumulated deficit | (228,141 | ) | — | (228,141 | ) | |||||||||
Accumulated other comprehensive income | (5 | ) | — | (5 | ) | |||||||||
Total stockholders’ equity (deficit) | (198,906 | ) | 224,400 | 25,494 | ||||||||||
Total liabilities and stockholders’ equity (deficit) | $ | 89,600 | $ | (3,970 | ) | $ | 85,630 | |||||||
RAAC as Adjusted | Berkshire Grey As Adjusted | Transaction Accounting Adjustments | Note 3 | Pro Forma Combined | ||||||||||||||
ASSETS | ||||||||||||||||||
CURRENT ASSETS | ||||||||||||||||||
Cash and cash equivalents | $ | 41,317 | $ | 50,630 | $ | 153,561 | (A) | $ | 245,508 | |||||||||
Accounts receivable | — | 2,669 | — | 2,669 | ||||||||||||||
Inventories | — | 2,719 | — | 2,719 | ||||||||||||||
Deferred fulfillment costs | — | 13,373 | — | 13,373 | ||||||||||||||
Prepaid expenses | 365 | 2,537 | — | 2,902 | ||||||||||||||
Deferred transaction costs | — | — | — | — | ||||||||||||||
Other current assets | — | 2,091 | — | 2,091 | ||||||||||||||
Total current assets | 41,682 | 74,019 | 153,561 | 269,262 | ||||||||||||||
Property and equipment - net | — | 10,466 | — | 10,466 | ||||||||||||||
Restricted cash | — | 1,121 | — | 1,121 | ||||||||||||||
Cash held in trust account | — | — | — | — | ||||||||||||||
Other non-current assets | — | 24 | — | 24 | ||||||||||||||
Total Assets | $ | 41,682 | $ | 85,630 | $ | 153,561 | $ | 280,873 | ||||||||||
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||||
CURRENT LIABILITIES | ||||||||||||||||||
Accounts payable | $ | — | $ | 5,412 | $ | — | $ | 5,412 | ||||||||||
Accrued expenses | 3,053 | 10,569 | — | 13,622 | ||||||||||||||
Contract liabilities | — | 23,765 | — | 23,765 | ||||||||||||||
Promisory Note - related party | 500 | 500 | ||||||||||||||||
Other current liabilities | — | 181 | — | 181 | ||||||||||||||
Total current liabilities | 3,553 | 39,927 | — | 43,480 | ||||||||||||||
Deferred underwriting fee payable | — | — | — | — | ||||||||||||||
Warrant liability | 29,603 | — | — | 29,603 | ||||||||||||||
Share-based compensation liability | — | 18,213 | — | 18,213 | ||||||||||||||
Other non-current liabilities | — | 1,996 | — | 1,996 | ||||||||||||||
Total Liabilities | 33,156 | 60,136 | — | 93,292 | ||||||||||||||
MEZZANINE EQUITY | ||||||||||||||||||
Redeemable convertible preferred stock | — | — | — | — | ||||||||||||||
Class A common stock subject to redemption | — | — | — | — | ||||||||||||||
STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||
Class A common stock | — | — | — | — | ||||||||||||||
Class B common stock | — | — | — | — | ||||||||||||||
Class C common stock | 1 | — | — | 1 | ||||||||||||||
Common stock | 1 | 20 | 2 | (E) | 23 | |||||||||||||
Additional paid-in capital | 51,240 | 253,620 | 110,843 | (D),(E) | 415,703 | |||||||||||||
Accumulated deficit | (42,716 | ) | (228,141 | ) | 42,716 | (E) | (228,141 | ) | ||||||||||
Accumulated other comprehensive income | — | (5 | ) | — | (5 | ) | ||||||||||||
Total stockholders’ equity (deficit) | 8,526 | 25,494 | 153,561 | 187,581 | ||||||||||||||
Total liabilities and stockholders’ equity (deficit) | $ | 41,682 | $ | 85,630 | $ | 153,561 | $ | 280,873 | ||||||||||
RAAC Historical | Berkshire Grey Historical | Pro Forma Adjustments | Note 3 | Pro Forma | ||||||||||||||||
Revenue | $ | — | $ | 8,468 | $ | — | $ | 8,468 | ||||||||||||
Cost of revenue | — | 9,938 | — | 9,938 | ||||||||||||||||
Gross profit | — | (1,470 | ) | — | (1,470 | ) | ||||||||||||||
Operating expenses: | ||||||||||||||||||||
General and administrative | — | 8,853 | 1,328 | (H) (I) | 10,181 | |||||||||||||||
Sales and marketing | — | 38,023 | — | 38,023 | ||||||||||||||||
Research and development | — | 28,051 | — | 28,051 | ||||||||||||||||
Change in fair value of warrant liability | 6,741 | — | — | 6,741 | ||||||||||||||||
Transaction costs | — | — | — | — | ||||||||||||||||
Compensation expense | — | — | — | — | ||||||||||||||||
Formation and operational costs | 4,486 | — | (4,486 | ) | (I) | — | ||||||||||||||
Total operating expenses | 11,227 | 74,927 | (3,158 | ) | 82,996 | |||||||||||||||
Loss from operations | (11,227 | ) | (76,397 | ) | 3,158 | (84,466 | ) | |||||||||||||
Other income (expense): | ||||||||||||||||||||
Interest income | — | 14 | — | 14 | ||||||||||||||||
Other income | — | (42 | ) | — | (42 | ) | ||||||||||||||
Interest income (expense) on marketable securities held in trust account | 47 | — | (47 | ) | (J) | — | ||||||||||||||
Unrealized gain (loss) on marketable securities held in trust account | — | — | — | (K) | — | |||||||||||||||
Net loss before income tax | (11,180 | ) | (76,425 | ) | 3,111 | (84,494 | ) | |||||||||||||
Income tax | — | 12 | — | 12 | ||||||||||||||||
Net loss | (11,180 | ) | (76,437 | ) | 3,111 | (84,506 | ) | |||||||||||||
Weighted average common shares outstanding | 10,658 | 3,782 | 228,347 | |||||||||||||||||
Net loss per common share - basic and diluted | $ | (1.05 | ) | $ | (20.21 | ) | $ | (0.37 | ) |
RAAC Historical | Berkshire Grey Historical | Pro Forma Adjustments | Note 3 | Pro Forma | ||||||||||||||
Revenue | $ | — | $ | 34,835 | $ | — | $ | 34,835 | ||||||||||
Cost of revenue | — | 32,009 | — | 32,009 | ||||||||||||||
Gross profit | — | 2,826 | — | 2,826 | ||||||||||||||
Operating expenses: | ||||||||||||||||||
General and administrative | — | 15,935 | 718 | (H) (I) | 16,653 | |||||||||||||
Sales and marketing | — | 12,910 | 12,910 | |||||||||||||||
Research and development | — | 35,806 | 35,806 | |||||||||||||||
Change in fair value of warrant liability | 590 | — | — | 590 | ||||||||||||||
Transaction costs | 828 | — | (828 | ) | (I) | — | ||||||||||||
Compensation expense | 52 | — | (52 | ) | (I) | — | ||||||||||||
Formation and operational costs | 173 | — | (173 | ) | (I) | — | ||||||||||||
Total operating expenses | 1,643 | 64,651 | (335 | ) | 65,959 | |||||||||||||
Loss from operations | (1,643 | ) | (61,825 | ) | 335 | (63,133 | ) | |||||||||||
Other income (expense): | ||||||||||||||||||
Interest income | — | 280 | — | 280 | ||||||||||||||
Other income | — | 3,907 | — | 3,907 | ||||||||||||||
Interest income (expense) on marketable securities held in trust account | 8 | — | (8 | ) | (J) | — | ||||||||||||
Unrealized gain (loss) on marketable securities held in trust account | (17 | ) | — | 17 | (K) | — | ||||||||||||
Net loss before income tax | (1,652 | ) | (57,638 | ) | 344 | (58,946 | ) | |||||||||||
Income tax | — | 5 | — | 5 | ||||||||||||||
Net loss | (1,652 | ) | (57,643 | ) | 344 | (58,951 | ) | |||||||||||
Weighted average common shares outstanding | 9,280 | 3,554 | 228,347 | |||||||||||||||
Net loss per common share - basic and diluted | $ | (0.18 | ) | $ | (16.22 | ) | $ | (0.26 | ) |
• | RAAC’s unaudited statement of operations for the six months ended June 30, 2021 and the related notes included thereto which are included elsewhere in this prospectus; and |
• | Berkshire Grey’s unaudited consolidated statements of operations for the six months ended June 30, 2021 and the related notes, included elsewhere in this prospectus. |
• | RAAC’s audited statement of operations for the year ended December 31, 2020; and |
• | Berkshire Grey’s audited consolidated statement of operations for the year ended December 31, 2020. |
(A) | Reflects the release of cash held in trust account less payment of deferred underwriting fees and RAAC transaction expenses. |
(in thousands) | Note | |||||||
RAAC cash held in trust account | (1 | ) | $ | 287,539 | ||||
PIPE - RAAC Investors | (2 | ) | 64,000 | |||||
PIPE - New Investors | (2 | ) | 101,000 | |||||
Payment to redeeming RAAC Stockholders | (3 | ) | (232,551 | ) | ||||
Payment of RAAC deferred underwriting commissions | (4 | ) | (10,063 | ) | ||||
Payment of RAAC accounting, legal and insurance fees | (5 | ) | (3,732 | ) | ||||
Payment of RAAC financial advisory fees | (6 | ) | (4,574 | ) | ||||
Payment of RAAC insurance premiums | (7 | ) | (790 | ) | ||||
Payment of Berkshire Grey accounting and legal fees | (8 | ) | (2,200 | ) | ||||
Payment of Berkshire Grey financial advisory fees | (9 | ) | (6,077 | ) | ||||
Excess cash to balance sheet from Business Combination | $ | 192,552 | ||||||
(1) | Represents the amount of the restricted investments and cash held in the trust account upon consummation of the Business Combination. |
(2) | Represents the aggregate gross proceeds of the PIPE Investment. |
(3) | Represents the payment to RAAC stockholders who are exercised redemption rights. |
(4) | Represents the payment of deferred RAAC IPO underwriting commissions by RAAC upon consummation of the Business Combination. |
(5) | Represents the aggregate of the estimated payments of accounting, legal, financial advisory and placement agent fees by RAAC upon consummation of the Business Combination. |
(6) | Represents payment of financial advisory fees by RAAC calculated as $4,500,000 plus approximately $74,000 in reimbursements. |
(7) | Represents payment of six year “tail” director and officer insurance premiums by RAAC. |
(8) | Represents payment of legal and accounting fees by Berkshire Grey. |
(9) | Represents payment of financial advisory fees by Berkshire Grey calculated as $5,000,000 plus and creditable against 2.75% of the sum of the cash held in the Trust Account net of redemptions and the PIPE Investment Amount. |
(B) | Reflects the release of cash held in trust account upon consummation of the Business Combination at closing (See Note 3(A)(1)). |
(C) | Reflects the payment of deferred RAAC IPO underwriting commissions by RAAC in the amount of approximately $10.1 million (see Note 3(A)(4)). The unaudited pro forma condensed combined balance sheet reflects payment of these costs as a reduction of cash, with a corresponding decrease in deferred underwriting commission liability. |
(D) | Post-Business Combination Class C common stock and warrant liabilities are classified as equity and liabilities, respectively. The following table represents the impact of the Business Combination and PIPE Investment on the number of shares of RAAC Class A common stock and represents the equity section: |
Common Stock | ||||||||||||||||||||||||||||||||||||||||
Number of Shares | Par Value | |||||||||||||||||||||||||||||||||||||||
(in thousands) | Class A Stock | Class B Stock | Class C Stock | Class A Stock | Class B Stock | Class C Stock | Berkshire Grey Stock | Additional paid-in capital | Accumulated deficit | Accumulated Other Comprehensive Income | ||||||||||||||||||||||||||||||
Pre-Business Combination - RAAC stockholders | — | 3,833 | 5,750 | $ | — | $ | — | $ | 1 | $ | — | $ | 24 | $ | (42,716 | ) | $ | — | ||||||||||||||||||||||
Pre-Business Combination - Berkshire Grey | — | — | — | 3 | — | — | 223,442 | 29,237 | (228,141 | ) | (5 | ) | ||||||||||||||||||||||||||||
Conversion of Class B common stock to Class A common stock | 3,833 | (3,833 | ) | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||
Reclassification of redeemable stock to Class A common stock | 28,750 | — | — | 3 | — | — | — | 287,497 | — | — | ||||||||||||||||||||||||||||||
Less: Redemption of redeemable shares | (23,252 | ) | — | — | (2 | ) | — | — | — | (232,549 | ) | — | — | |||||||||||||||||||||||||||
Reclassification of Berkshire Grey liability classified Stock awards to Equity | — | — | — | — | — | — | — | 3,158 | — | — | ||||||||||||||||||||||||||||||
Berkshire Grey Stockholders | 196,766 | — | — | 20 | — | — | — | (20 | ) | — | — | |||||||||||||||||||||||||||||
PIPE - RAAC Shareholders | 6,400 | — | — | 1 | — | — | — | 64,000 | — | — | ||||||||||||||||||||||||||||||
PIPE - New Investors | 10,100 | — | — | 1 | — | — | — | 101,000 | — | — | ||||||||||||||||||||||||||||||
Balances after share transactions of Combined Entity | 222,597 | — | 5,750 | 26 | — | 1 | 223,442 | $ | 252,347 | (270,857 | ) | (5 | ) | |||||||||||||||||||||||||||
Estimated transaction costs | — | — | — | — | — | — | — | (17,373 | ) | — | — | |||||||||||||||||||||||||||||
Elimination of historical accumulated deficit of RAAC | — | — | — | — | — | — | — | (42,716 | ) | 42,716 | — | |||||||||||||||||||||||||||||
Elimination of historical par amounts for Class A, Class B | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Elimination of historical stock of Berkshire Grey | — | — | — | (3 | ) | — | — | (223,442 | ) | 223,445 | — | — | ||||||||||||||||||||||||||||
Post-Business Combination | 222,597 | — | 5,750 | $ | 23 | $ | — | $ | 1 | $ | — | $ | 415,703 | $ | (228,141 | ) | $ | (5 | ) | |||||||||||||||||||||
(E) | Reflects payment of Berkshire Grey related transaction expenses, including a reduction of deferred transaction costs and accrued liabilities. |
(F) | Share-based compensation liability reflects restricted stock awards issued to an executive officer, who purchased the awards using the proceeds received from the partial recourse secured promissory note issued by the Company. In conjunction with the Transactions, the promissory note was settled through the repurchase of 174,243 shares of vested common stock. The pro forma adjustments recorded reduces the share-based liability to account for the repurchase of shares described above. |
(G) | Reflects conversion of preferred stock, payment of transaction expenses (see note 3(E) and settlement of promissory note (see note 3(F)). |
(H) | In conjunction with the Transactions, a partial recourse promissory note issued to an executive officer, the proceeds of which were used to purchase restricted stock awards, was settled through the repurchase of 174,243 shares of vested common stock. This adjustment reflects a corresponding reduction in stock-based compensation expense as a result of fewer outstanding shares associated with the stock award of approximately $3.3 million and $0.4 million for the six months ended June 30, 2021 and year ended December 31, 2020, respectively. The adjustment assumes the promissory note is settled via repurchase of at the time pro forma adjustment occurred. |
(I) | Reflects the reclassification of transaction costs, compensation expense and formation and operational costs incurred by RAAC of approximately $3.3 million and $1.0 million for the six months ended June 30, 2021 and year ended December 31, 2020, respectively, to General and Administrative expenses on the condensed combined statements of operations. |
(J) | Reflects the elimination of interest income earned on marketable securities held in the RAAC trust account. |
(K) | Reflects the elimination of unrealized loss on marketable securities held in the RAAC trust account. |
(in thousands, except per share amounts) | Six Months Ended June 30, 2021 | Year Ended December 31, 2020 | ||||||
Pro forma net loss | $ | (84,506 | ) | $ | (58,951 | ) | ||
Pro forma weighted average shares outstanding-basic and diluted | 228,347 | 226,526 | ||||||
Pro forma net loss per share-basic and diluted | $ | (0.37 | ) | $ | (0.26 | ) | ||
Pro forma weighted average shares outstanding-basic and diluted | ||||||||
RAAC public stockholders | 5,498 | 5,498 | ||||||
RAAC Sponsor | 9,583 | 9,583 | ||||||
Total RAAC | 15,081 | 15,081 | ||||||
Berkshire Grey(a) | 196,766 | 194,945 | ||||||
PIPE Shares | 16,500 | 16,500 | ||||||
Pro forma weighted average shares outstanding-basic and diluted (b) | 228,347 | 226,526 | ||||||
(a) | Excludes approximately 28.2 million and 33.6 million Berkshire consideration shares for the six months ended June 30, 2021 and for year ended December 31 2020, respectively, that will be issued upon the occurrence of future events (i.e., exercise of stock options). Total consideration to be issued to Berkshire Grey is $2.25 billion or 225 million shares ($10 per share price). The total shares to be issued includes all issued and outstanding Berkshire Grey common and preferred stock plus shares underlying unvested stock options. Accordingly, the weighted average pro forma shares outstanding at close has been adjusted to exclude the portion of consideration shares that will be unvested, unissued, and/or unexercised at the closing of the Business Combination. |
(b) | For the purposes of applying the if converted method for calculating diluted earnings per share, it was assumed that all Berkshire Grey stock options are exchanged for Class A common stock. However, since this results in anti-dilution, the effect of such exchange was not included in calculation of diluted loss per share. Shares underlying these instruments include approximately 30.9 million Berkshire consideration shares for unvested, unissued, and/or unexercised stock options. |
For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||||||||||||||||||
(Dollars in thousands) | 2021 | 2020 | Change | 2021 | 2020 | Change | ||||||||||||||||||||||||||
Revenue | $ | 4,503 | $ | 2,752 | $ | 1,751 | 64 | % | $ | 8,468 | $ | 29,028 | $ | (20,560 | ) | (71 | )% |
For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||||||||||||||||||
(Dollars in thousands) | 2021 | 2020 | Change | 2021 | 2020 | Change | ||||||||||||||||||||||||||
Cost of Revenue | $ | 5,240 | $ | 2,658 | $ | 2,582 | 97 | % | $ | 9,938 | $ | 27,392 | $ | (17,454 | ) | (64 | )% |
For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||||||||||||||||||
(Dollars in thousands) | 2021 | 2020 | Change | 2021 | 2020 | Change | ||||||||||||||||||||||||||
Gross (Loss) Profit | $ | (737 | ) | $ | 94 | $ | (831 | ) | (884 | )% | $ | (1,470 | ) | $ | 1,636 | $ | (3,106 | ) | (190 | )% | ||||||||||||
Gross Margin | (16 | )% | 3 | % | (20 | )% | (17 | )% | 6 | % | (23 | )% |
For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||||||||||||||||||
(Dollars in thousands) | 2021 | 2020 | Change | 2021 | 2020 | Change | ||||||||||||||||||||||||||
General and Administrative | $ | 4,710 | $ | 2,877 | $ | 1,833 | 64 | % | $ | 8,853 | $ | 6,722 | $ | 2,131 | 32 | % | ||||||||||||||||
% of Operating Expenses | 15 | % | 21 | % | 12 | % | 25 | % |
For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||||||||||||||||||
(Dollars in thousands) | 2021 | 2020 | Change | 2021 | 2020 | Change | ||||||||||||||||||||||||||
Sales and Marketing | $ | 10,540 | $ | 1,667 | $ | 8,873 | 532 | % | $ | 38,023 | $ | 3,338 | $ | 34,685 | 1039 | % | ||||||||||||||||
% of Operating Expenses | 34 | % | 12 | % | 51 | % | 12 | % |
For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||||||||||||||||||
(Dollars in thousands) | 2021 | 2020 | Change | 2021 | 2020 | Change | ||||||||||||||||||||||||||
Research and Development | $ | 15,741 | $ | 9,163 | $ | 6,578 | 72 | % | $ | 28,051 | $ | 17,200 | $ | 10,851 | 63 | % | ||||||||||||||||
% of Operating Expenses | 51 | % | 67 | % | 37 | % | 63 | % |
For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||||||||||||||||||
(Dollars in thousands) | 2021 | 2020 | Change | 2021 | 2020 | Change | ||||||||||||||||||||||||||
Interest Income, Net | $ | 3 | $ | 8 | $ | (5 | ) | -63 | % | $ | 14 | $ | 273 | $ | (259 | ) | -95 | % |
For the Years Ended December 31, | Change in Revenue | |||||||||||||||
(Dollars in thousands) | 2020 | 2019 | $ | % | ||||||||||||
Revenue | $ | 34,835 | $ | 7,972 | $ | 26,863 | 337 | % |
For the Years Ended December 31, | Change in Cost of Revenue | |||||||||||||||
(Dollars in thousands) | 2020 | 2019 | $ | % | ||||||||||||
Cost of Revenue | $ | 32,009 | $ | 9,974 | $ | 22,035 | 221 | % |
For the Years Ended December 31, | Change in Gross Profit | |||||||||||||||
(Dollars in thousands) | 2020 | 2019 | $ | % | ||||||||||||
Gross Profit | $ | 2,826 | $ | (2,002 | ) | $ | 4,828 | (241 | )% |
For the Years Ended December 31, | Change in Gross Margin | |||||||||||
2020 | 2019 | |||||||||||
Gross Margin | 8 | % | (25 | )% | 33 | % |
For the Years Ended December 31, | Change in Expenses | |||||||||||||||
(Dollars in thousands) | 2020 | 2019 | $ | % | ||||||||||||
General and Administrative | $ | 15,935 | $ | 15,152 | $ | 783 | 5 | % | ||||||||
% of Operating Expenses | 25 | % | 31 | % |
For the Years Ended December 31, | Change in Expenses | |||||||||||||||
(Dollars in thousands) | 2020 | 2019 | $ | % | ||||||||||||
Sales and Marketing | $ | 12,910 | $ | 5,272 | $ | 7,638 | 145 | % | ||||||||
% of Operating Expenses | 20 | % | 11 | % |
For the Years Ended December 31, | Change in Expenses | |||||||||||||||
(Dollars in thousands) | 2020 | 2019 | $ | % | ||||||||||||
Research and Development | $ | 35,806 | $ | 27,805 | $ | 8,001 | 29 | % | ||||||||
% of Operating Expenses | 55 | % | 58 | % |
For the Years Ended December 31, | Change in Interest Income | |||||||||||||||
(Dollars in thousands) | 2020 | 2019 | $ | % | ||||||||||||
Interest Income | $ | 280 | $ | 579 | $ | (299 | ) | (52 | )% |
For the Years Ended December 31, | Change in Other Income | |||||||||||||||
(Dollars in thousands) | 2020 | 2019 | $ | % | ||||||||||||
Other Income | $ | 3,907 | $ | 142 | $ | 3,765 | 2,651 | % |
For the Years Ended December 31, | For the Three Months Ended June 30, | For the Six Months Ended June 30, | ||||||||||||||||||||||
(Dollars in thousands) | 2020 | 2019 | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||
Net loss | $ | (57,643 | ) | $ | (49,511 | ) | $ | (31,754 | ) | $ | (9,683 | ) | $ | (76,437 | ) | $ | (21,425 | ) | ||||||
Interest income, net | $ | (280 | ) | $ | (579 | ) | $ | (3 | ) | $ | (8 | ) | $ | (14 | ) | $ | (273 | ) | ||||||
Income tax expense | $ | 5 | $ | 1 | $ | 7 | $ | — | $ | 12 | $ | — | ||||||||||||
Depreciation and amortization | $ | 1,006 | $ | 312 | $ | 671 | $ | 800 | $ | 1,217 | $ | 1,000 | ||||||||||||
EBITDA | $ | (56,912 | ) | $ | (49,777 | ) | $ | (31,079 | ) | $ | (8,891 | ) | $ | (75,222 | ) | $ | (20,698 | ) | ||||||
Stock-based compensation | $ | 6,021 | $ | 12,034 | $ | 5,309 | $ | 316 | $ | 29,488 | $ | 1,259 | ||||||||||||
Adjusted EBITDA | $ | (50,891 | ) | $ | (37,743 | ) | $ | (25,770 | ) | $ | (8,575 | ) | $ | (45,734 | ) | $ | (19,439 | ) | ||||||
For the Six Months Ended June 30, | ||||||||
(Dollars in thousands) | 2021 | 2020 | ||||||
Net cash used in operating activities | $ | (39,340 | ) | $ | (35,516 | ) | ||
Net cash used in investing activities | $ | (2,139 | ) | $ | (2,114 | ) | ||
Net cash provided by financing activities | $ | 495 | $ | 32 | ||||
Effect of exchange rate on cash | $ | (43 | ) | $ | — | |||
Net decrease in cash, cash equivalents and restricted cash | $ | (41,027 | ) | $ | (37,598 | ) | ||
• | Intelligence Software AI-enabled capabilities for individual modules, such as picking and mobility, but also that provide system-level intelligences and orchestration of such robots to achieve overall system-wide performance. |
• | Automated Picking Platform |
• | Intelligent Mobile Robotic Platform |
• | Amplification Robotics & Automation — |
• | Cloud Analytics Platform |
• | Cloud AI |
• | Holistic Sensing and Perception |
• | Enterprise APIs |
• | Wrapping & Incorporation of Third-Party and Other Legacy Systems |
• | Brownfield and Greenfield Installation |
• | Modularity, Flexibility, and Scalability |
• | Dynamically Adjustable Performance |
• | Mobile Data Access for Customers |
• | Full Analysis & Design we start with an analysis of the customer’s processes, product flows, goods handled, and even the physical layout of their existing systems, and use proprietary analysis |
methodologies and simulation to create solutions using our product modules and technological capabilities for our customers. |
• | Installation & Commissioning |
• | Professional Services |
• | Robotic Pick & Pack |
• | Robotic Induction Systems |
• | Robotic Pick & Sortation |
• | Intelligent Mobility |
• | Versatility odd-shaped boxes, containers, apparel, electronics, housewares, packaged food, childcare products, pet care items, health and beauty items, and other general merchandise. Our vision systems, AI and machine learning algorithms combined with haptics and gripping technology enable our solutions to handle wide ranges of products without the need forpre-programming or other manual processes to “teach” our robots. Further, our technology and product modules industry agnostic — they can be applied broadly to businesses that fill orders or perform logistics. |
• | Speed and Accuracy |
• | Reliability |
• | Flexibility and Scalability |
• | Efficiency and Economic Benefits |
• | Expanding the capabilities and making improvements to our technology |
• | Expand the capabilities of our artificial intelligence software platforms value-add capability, improve system performance and expand solutions offerings. |
• | Expand our product module and solution offerings |
Location | ~Size (sq ft) | Lease Expiration | Purpose | |||
Bedford, MA (Main) | 70,000 | 2031 | Innovation Center & Headquarters | |||
Lexington, MA | 31,000 | April 2022 | R&D and Admin | |||
Pittsburgh, PA | 20,500 | September 2025 | R&D | |||
Reading, UK | 1,000 | December 2021 | EMEA S&M |
Name | Age | Position | ||
Thomas Wagner | 54 | Chief Executive Officer and Class III Director | ||
Steven Johnson | 57 | President & Chief Operating Officer | ||
Mark Fidler | 50 | Chief Financial Officer | ||
John K. Delaney | 58 | Class III Director | ||
Peter Barris | 70 | Class II Director | ||
Sven Strohband | 48 | Class II Director | ||
Fiona P. Dias | 55 | Class I Director | ||
Serena Wolfe | 42 | Class I Director |
• | we have independent director representation on our audit, compensation and nominating and corporate governance committees, and our independent directors meet regularly in executive sessions without the presence of our corporate officers or non-independent directors; |
• | at least one of our directors qualifies as an “audit committee financial expert” as defined by the SEC; and |
• | we have implemented a range of other corporate governance best practices, including implementing a robust director education program. |
• | the Class I directors are Fiona P. Dias and Serena Wolfe, and their terms will expire at our 2022 annual meeting of stockholders; |
• | the Class II directors are Peter Barris and Sven Strohband, and their terms will expire at our 2023 annual meeting of stockholders; and |
• | the Class III directors are Mr. Delaney and Dr. Wagner and their terms will expire at the 2024 annual meeting of stockholders. |
• | appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered public accounting firm; |
• | discussing with our independent registered public accounting firm their independence from management; |
• | reviewing, with our independent registered public accounting firm, the scope and results of their audit; |
• | approving all audit and permissible non-audit services to be performed by our independent registered public accounting firm; |
• | overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the quarterly and annual financial statements that we file with the SEC; |
• | overseeing our financial and accounting controls and compliance with legal and regulatory requirements; |
• | reviewing our policies on risk assessment and risk management; |
• | reviewing related person transactions; and |
• | establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls or auditing matters. |
• | reviewing and approving the corporate goals and objectives, evaluating the performance of and reviewing and approving, (either alone or, if directed by our board of directors, in conjunction with a |
majority of the independent members of our board of directors) the compensation of our Chief Executive Officer; |
• | overseeing an evaluation of the performance of and reviewing and setting or making recommendations to our board of directors regarding the compensation of our other executive officers; |
• | reviewing and approving or making recommendations to our board of directors regarding our incentive compensation and equity-based plans, policies and programs; |
• | reviewing and approving all employment agreement and severance arrangements for our executive officers; |
• | making recommendations to our board of directors regarding the compensation of our directors; and |
• | retaining and overseeing any compensation consultants. |
• | identifying individuals qualified to become members of our board of directors, consistent with criteria approved by our board of directors; |
• | overseeing succession planning for our Chief Executive Officer and other executive officers; |
• | periodically reviewing our board’s leadership structure and recommending any proposed changes to our board of directors; |
• | overseeing an annual evaluation of the effectiveness of our board of directors and its committees; and |
• | developing and recommending to our board of directors a set of corporate governance guidelines. |
• | Thomas Wagner, Berkshire Grey’s Chief Executive Officer; |
• | Steven Johnson, Berkshire Grey’s President and Chief Operating Officer; and |
• | Mark Fidler, Berkshire Grey’s Chief Financial Officer. |
Name and principal position | Year | Salary | Bonus (1) | Stock Awards | Option Awards (2) | Non-Equity Incentive Plan Compensation (3) | Nonqualified deferred compensation earnings | All Other Compensation (4) | Total | |||||||||||||||||||||||||||
Thomas Wagner Chief Executive Officer | 2020 | $ | 341,154 | $ | — | $ | — | $ | 1,307,300 | (5) | $ | 187,500 | $ | — | $ | 11,400 | $ | 1,847,354 | ||||||||||||||||||
Steven Johnson President and Chief Operating Officer | 2020 | 300,000 | — | — | — | 150,000 | — | 6,959 | 456,959 | |||||||||||||||||||||||||||
Mark Fidler Chief Financial Officer (6) | 2020 | 113,077 | 58,333 | — | 1,441,578 | — | — | 942 | 1,613,930 |
(1) | Mr. Fidler’s 2020 bonus was guaranteed as described in his offer letter. |
(2) | Represents the aggregate grant date fair value of stock option awards computed in accordance with FASB ASC Topic 718, rather than an amount paid to or realized by the named executive officer. The value of the grants was determined by application of the Black-Sholes option-pricing model with no discount for estimated forfeitures. Key assumptions include the underlying value of the common stock, risk free rate of return, expected life of the option, expected stock price volatility and expected dividend yield. |
(3) | Amounts shown reflect discretionary bonuses to each of Dr. Wagner and Mr. Johnson earned in 2020 with respect to the achievement of predetermined corporate and individual performance goals, as determined by Berkshire Grey’s board of directors. |
(4) | The amounts reported represent 401(k) matching contributions made by us. |
(5) | The fair value of option awards as set forth above includes $0, which is the aggregate grant date fair value of 500,044 stock options that will vest upon the achievement of performance criteria to be determined by Berkshire Grey’s board of directors, based on probable achievement of such criteria. Assuming maximum achievement, the grant date fair value of the performance-based stock options granted to Dr. Wagner is $0. In accordance with FASB ASC Topic 718, the fair value of these stock options will not be determinable |
until such criteria are determined. The fair value of these awards is $23.4 million and was determined in July 2021 when the performance criteria for the awards was determined by Berkshire Grey’s board of directors. |
(6) | Mr. Fidler joined Berkshire Grey on September 1, 2020. |
Option Awards | Stock Awards | |||||||||||||||||||||||||||||||||||||||
Name | Date of Grant | Number of Securities Underlying Unexercised Options (#) Exercisable | Number of Securities Underlying Unexercised Options (#) Unexercisable | Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) | Option Exercise Price ($) | Option Expiration Date | Number of Shares or Units of Stock That Have Not Vested (#) | Market Value of Shares or Units of Stock That Have Not Vested ($) (1) | Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#) | Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares or Other Rights That Have Not Vested ($) (1) | ||||||||||||||||||||||||||||||
Thomas Wagner | 11/4/2020 | (2) | — | 346,540 | — | 6.70 | 11/4/2030 | — | — | — | — | |||||||||||||||||||||||||||||
Chief Executive Officer | 11/4/2020 | (3) | — | — | 105,653 | 6.70 | 11/4/2030 | — | — | — | — | |||||||||||||||||||||||||||||
12/9/2020 | (4) | — | 36,671 | — | 6.70 | 12/9/2030 | — | — | — | — | ||||||||||||||||||||||||||||||
12/9/2020 | (5) | — | — | 394,391 | 6.70 | 12/9/2030 | — | — | — | — | ||||||||||||||||||||||||||||||
Steven Johnson | 10/28/2019 | (6) | — | — | — | — | — | 421,909 | 5,489,036 | 595,936 | 7,753,127 | |||||||||||||||||||||||||||||
President and Chief Operating Officer | ||||||||||||||||||||||||||||||||||||||||
Mark Fidler | 11/4/2020 | (7) | — | 422,610 | — | 6.70 | 11/4/2030 | — | — | — | — | |||||||||||||||||||||||||||||
Chief Financial Officer |
(1) | Market value of unvested shares is based on management’s retrospective determination of the fair market value of such shares as of December 31, 2020: $13.01. |
(2) | The stock option is subject to time-based vesting, such that the stock options vests over four years, commencing on November 4, 2020, with 25% of the award vesting on the first anniversary of such date, followed by equal monthly vesting thereafter. In addition, the stock option is subject to automatic 100% acceleration upon a “change in control” (as defined in the stock option agreement). |
(3) | The stock options vest at the discretion of the board of directors for achievement of performance milestones determined by the board of directors. The maximum number of options to acquire shares of stock Dr. Wagner may earn in connection with this award is 105,653. In addition, the stock option is subject to automatic 100% acceleration upon a “change in control” (as defined in the stock option agreement). |
(4) | The stock option is subject to time-based vesting, such that the stock options vests over four years, commencing on December 9, 2020, such that 25% of the award vests upon the first anniversary of such date, followed by equal monthly vesting thereafter. In addition, the stock option is subject to automatic 100% acceleration upon a “change in control” (as defined in the stock option agreement). |
(5) | The stock options vest at the discretion of the Board for achievement of performance milestones determined by the board of directors. The maximum number of options to acquire shares of stock Dr. Wagner may earn in connection with this award is 394,391. In addition, the stock option is subject to automatic 100% acceleration upon a change in control (as defined in the stock option agreement). |
(6) | The restricted stock awards are subject to time- and performance-based vesting in equal parts. The time-based vesting portion the restricted stock awards vest over four years, commencing on October 28, 2019, such that 25% of the award vests upon the first anniversary of such date, followed by equal monthly vesting thereafter. The performance-based vesting portion of the awards vests upon the achievement of corporate financial performance criteria. |
(7) | The stock option is subject to time-based vesting, such that the stock options vest over four years, commencing on September 1, 2020, such that 25% of the award vests upon the first anniversary of such date, followed by equal monthly vesting thereafter. |
Name | Fees Earned or Paid in Cash ($) | Stock Awards ($) | Option Awards ($) | Non-Equity Incentive Plan Compensation ($) | Nonqualified Deferred Compensation Earnings ($) | All Other Compensation ($) | Total ($) | |||||||||||||||||||||
Peter Barris | — | — | — | — | — | — | — | |||||||||||||||||||||
Sven Strohband | — | — | — | — | — | — | — | |||||||||||||||||||||
Kenichi Yoshida | — | — | — | — | — | — | — |
Member Annual Fee | Committee Chair Annual Fee | |||||||
Board of Directors | $ | 40,000 | $ | — | ||||
Audit Committee | $ | 10,000 | $ | 20,000 | ||||
Compensation Committee | $ | 7,500 | $ | 15,000 | ||||
Nominating and Corporate Governance Committee | $ | 5,000 | $ | 10,000 |
• | each person known to us to be the beneficial owner of more than 5% of our Company common stock; |
• | each of our named executive officers and directors; and |
• | all of our executive officers and directors as a group. |
Class A Common Stock | Class C Common Stock (2) | |||||||||||||||
Name and Address of Beneficial Owner (1) | Number of Shares | Percentage of Class Outstanding | Number of Shares | Percentage of Class | ||||||||||||
5% Holders (Other than Directors and Named Executive Officer) | ||||||||||||||||
RAAC Management (the Sponsor) (3) | 3,735,333 | 1.68 | % | 5,628,000 | 97.88 | % | ||||||||||
Entities Affiliated with Khosla Ventures (4) | 56,567,914 | 25.41 | % | — | — | |||||||||||
Entities Affiliated with New Enterprise Associates (5) | 38,226,621 | 17.17 | % | — | — | |||||||||||
Canaan X, L.P. (6) | 14,302,523 | 6.437 | % | — | — | |||||||||||
SVF II BG (DE) LLC (7) | 65,567,317 | 29.46 | % | — | — | |||||||||||
Directors and Named Executive Officers | ||||||||||||||||
Thomas Wagner (8) | 6,198,141 | 2.78 | % | — | — | |||||||||||
Steve Johnson (9) | 5,979,436 | 2.69 | % | — | — | |||||||||||
Mark Fidler 10) | 620,818 | * | — | — | ||||||||||||
Peter Barris (11) | — | — | — | — | ||||||||||||
Sven Strohband (4) | 56,567,920 | 25.41 | % | — | — | |||||||||||
Fiona P. Dias | — | — | — | — | ||||||||||||
Serena Wolfe | — | — | — | — | ||||||||||||
John K. Delaney (3) | 3,735,333 | 1.68 | % | 5,628,000 | 97.88 | % | ||||||||||
All current directors and executive officers as a group (8 individuals) | 73,101,648 | 32.84 | % | 5,628,000 | 97.88 | % |
* | Less than 1%. |
(1) | Unless otherwise noted, the business address of each of the following entities or individuals is c/o Berkshire Grey, Inc., 140 South Road, Bedford, Massachusetts 01730. |
(2) | The shares of Class C common stock will automatically convert into shares of Class A Common Stock upon the earlier of (i) meeting certain stock price performance thresholds, and (ii) the date on which we complete |
a merger, stock exchange, reorganization or other similar transaction that results in both a change of control and all of the public stockholders having the right to exchange their shares of Class A Common Stock for cash, securities or other property, in each case, on a one-for-one |
(3) | RAAC Management LLC, the Sponsor, is the record holder of the 3,735,333 shares of Class A Common Stock and the 5,628,000 shares of Class C common stock reported herein. The members of the Sponsor are Acceleration Capital Management LLC (“ACM”) and Revolution Special Opportunities LLC (“RSO”). John K. Delaney is the managing member of ACM. The members of the Sponsor elect and remove its managers. By virtue of control over our sponsor, Mr. Delaney may be deemed to beneficially own shares held by our sponsor. |
(4) | Consists of (a) 33,981,955 shares held by Khosla Ventures Seed B, LP, (b) 1,928,958 shares held by Khosla Ventures Seed B (CF), LP, and (c) 20,657,001 shares held by Khosla Ventures V, LP. Dr. Strohband is a Partner and Managing Director at Khosla Ventures and may be deemed to have beneficial ownership with respect to these shares. The address for these entities is 2128 Sand Hill Road, Menlo Park, CA 94025. |
(5) | Consists of (a) 38,183,023 shares held by New Enterprise Associates 15, L.P. (NEA 15) and (b) 43,598 shares held by NEA Ventures 2016, L.P. (Ven 2016). The shares directly held by NEA 15 are indirectly held by NEA Partners 15, L.P. (NEA Partners 15) the sole general partner of NEA 15, NEA 15 GP, LLC (NEA 15 LLC) the sole general partner of NEA Partners 15 and each of the individual managers of NEA 15 LLC. The individual managers (the Managers) of NEA 15 LLC are Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Joshua Makower, Scott D. Sandell and Peter Sonsini. The shares directly held by Ven 2016 are indirectly held by Karen P. Welsh, the general partner of Ven 2016. NEA Partners 15, NEA 15 LLC and the Managers share voting and dispositive power with regard to the shares held by NEA 15. Karen P. Welsh shares voting and dispositive power with regard to the shares held by Ven 2016. All indirect holders of the above referenced shares disclaim beneficial ownership of all applicable shares, except to the extent of their actual pecuniary interest therein. The address for these entities is 1954 Greenspring Drive, Suite 600, Timonium, MD 21093. |
(6) | Consists of 14,302,523 shares of Class A Common Stock held by Canaan X, L.P. The address for this entity is 285 Riverside Avenue, Suite 250, Westport, CT 06880. |
(7) | Consists of 65,567,317shares held by SVF II BG (DE) LLC. Entities affiliated with SVF II BG (DE) LLC, whose shares are aggregated for the purposes of reporting ownership information, include SVF II Holdings (DE) L.P., SVF II Aggregator (Jersey) L.P. and SoftBank Vision Fund II-2 L.P (“SoftBank Vision Fund II”). SB Investment Advisers (UK) Limited, or SBIA UK, has been appointed as alternative investment fund manager (“AIFM”) and is exclusively responsible for managing SoftBank Vision Fund II in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SoftBank Vision Fund II, SBIA UK is exclusively responsible for making all final decisions related to the acquisition, structuring, financing, voting and disposal of SoftBank Vision Fund II’s investments, including as held by SVF II BG (DE) LLC. The address for this entity is c/o SB Investment Advisers (US) Inc., 1 Circle Star Way, 2F, San Carlos, CA 94070. |
(8) | Consists of 4,709,752 shares and 1,488,389 stock options that will vest within 60 days of August 13, 2021 held directly by Dr. Wagner. |
(9) | Includes 2,477,805 shares of restricted stock subject to time-based vesting and 3,498,631 shares of restricted stock subject to performance-based vesting. |
(10) | Consists of 620,798 stock options that will vest within 60 days of August 13, 2021 held directly by Mr. Fidler. |
(11) | Excludes the shares referenced in footnote (5) above because, while Mr. Barris is the Chairman at New Enterprise Associates, Mr. Barris does not have voting or dispositive power over any of the shares directly held by NEA 15 or Ven 2016 referenced in footnote (5) above. |
Shares Beneficially Owned Prior to the Offering | Number of Shares Being Offered | Shares Beneficially Owned After the Offering | Warrants Beneficially Owned Prior to the Offering | Number of Warrants Being Offered | Warrants Beneficially Owned After the Offering | |||||||||||||||||||||||||||||||||||
Name of Selling Stockholder | Number | Percentage | Number | Percentage | Number | Percentage | Number | Percentage | ||||||||||||||||||||||||||||||||
RAAC Management LLC (1) | 14,530,000 | 6.5 | % | 14,530,000 | — | — | 5,166,667 | 35.0 | % | 5,166,667 | — | — | ||||||||||||||||||||||||||||
Entities Affiliated with Khosla Ventures (2) | 56,567,914 | 25.4 | % | 56,567,914 | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||
Entities Affiliated with New Enterprise Associates (3) | 38,226,621 | 17.2 | % | 38,226,621 | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||
Canaan X, L.P. (4) | 14,302,523 | 6.4 | % | 14,302,523 | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||
SVF II BG (DE) LLC (5) | 65,567,317 | 29.5 | % | 65,567,317 | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||
Thomas Wagner | 6,198,199 | 2.8 | % | 4,709,752 | 1,488,447 | * | — | — | — | — | — | |||||||||||||||||||||||||||||
Ghisallo Master Fund LP (6) | 800,000 | * | 800,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Suvretta Long Master Fund, LTD. (7) | 1,000 | * | 1,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Suvretta Master Fund, LTD. (8) | 199,000 | * | 199,000 | — | — | — | — | — | — | — |
Shares Beneficially Owned Prior to the Offering | Number of Shares Being Offered | Shares Beneficially Owned After the Offering | Warrants Beneficially Owned Prior to the Offering | Number of Warrants Being Offered | Warrants Beneficially Owned After the Offering | |||||||||||||||||||||||||||||||||||
Name of Selling Stockholder | Number | Percentage | Number | Percentage | Number | Percentage | Number | Percentage | ||||||||||||||||||||||||||||||||
Alberta Investment Management Corporation (9) | 200,000 | * | 200,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Alyeska Master Fund, L.P. (10) | 600,000 | * | 600,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Athanor International Master Fund, LP (11) | 188,900 | * | 188,900 | — | — | — | — | — | — | �� | ||||||||||||||||||||||||||||||
Athanor Master Fund, LP (12) | 811,100 | * | 811,100 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
BlackRock, Inc. (13) | 1,700,000 | * | 1,700,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Brookdale Global Opportunity Fund (14) | 296,000 | * | 296,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Brookdale International Partners, L.P. (15) | 504,000 | * | 504,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Chachacha 2019 Trust DTD 9/20/2019 (16) | 3,935,000 | 1.8 | % | 3,935,000 | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||
GoldenTree Asset Management LP, as investment advisor to Crown Managed Accounts SPC – Crown/Goldentree Segregated Portfolio (17) | 22,850 | * | 22,850 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Entities affiliated with Diameter Capital Partners LP (18) | 300,000 | * | 300,000 | — | — | 297,289 | 2.0 | % | — | 297,289 | 2.0 | % | ||||||||||||||||||||||||||||
GoldenTree Asset Management LP, as investment advisor to Goldentree Master Fund, LTD. (19) | 853,905 | * | 853,905 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
GoldenTree Asset Management LP, as investment advisor to GoldenTree Multi Sector-C, LP(20) | 7,120 | * | 7,120 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
GoldenTree Asset Management LP, as investment advisor to GoldenTree V1 Master Fund, LP (21) | 35,700 | * | 35,700 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Hedosophia Public Investments Limited (22) | 2,000,000 | * | 2,000,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
GoldenTree Asset Management LP, as investment advisor to Gingko Tree, LLC (23) | 52,065 | * | 52,065 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
GoldenTree Asset Management LP, as investment advisor to Guadalupe Fund, LP (24) | 9,560 | * | 9,560 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Integrated Core Strategies (US) LLC (25) | 400,000 | * | 400,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
GoldenTree Asset Management LP, as investment advisor to Louisiana State Employees’ Retirement System (26) | 11,485 | * | 11,485 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
MA Multi-Sector Opportunistic Fund, LP (27) | 7,315 | * | 7,315 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
MWIS – Market Neutral Tops Fund (28) | 25,370 | * | 25,370 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
MMF LT, LLC (29) | 500,000 | * | 500,000 | — | — | 100,000 | * | — | 100,000 | * | ||||||||||||||||||||||||||||||
MWIS – Eureka Fund (30) | 251,865 | * | 251,865 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
MWIS – Systematic Alpha Plus Fund (31) | 7,250 | * | 7,250 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
MWIS – Tops Fund (32) | 15,515 | * | 15,515 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Connor Nowinski | 5,000 | * | 5,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
PBCAY One Limited (33) | 93,590 | * | 93,590 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Riverview Group LLC (34) | 100,000 | * | 100,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Justin Saslaw | 5,000 | * | 5,000 | — | — | — | — | — | — | — |
Shares Beneficially Owned Prior to the Offering | Number of Shares Being Offered | Shares Beneficially Owned After the Offering | Warrants Beneficially Owned Prior to the Offering | Number of Warrants Being Offered | Warrants Beneficially Owned After the Offering | |||||||||||||||||||||||||||||||||||
Name of Selling Stockholder | Number | Percentage | Number | Percentage | Number | Percentage | Number | Percentage | ||||||||||||||||||||||||||||||||
Schonfeld Strategic 460 Fund LLC (35) | 200,000 | * | 200,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Steven Trieu Living Trust DTD 4.3.12 (36) | 50,000 | * | 50,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Ravikant Tanuku (37) | 5,000 | * | 5,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
TCIM Opportunities I LTD. (33) | 200,093 | * | 200,093 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Toms Capital Investments LLC (33) | 206,317 | * | 206,317 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Washington Harbour Capital Master Fund, LP (38) | 960,000 | * | 960,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Washington Harbour Capital Long Only Master Fund, LP (38) | 40,000 | * | 40,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
XN Exponent Master Fund LP (39) | 900,000 | * | 900,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Steven A. Musele (40) | 40,000 | * | 40,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Phyllis R. Caldwell (40) | 40,000 | * | 40,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Jason M. Fish (40) | 40,000 | * | 40,000 | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
Andrew Wallace (41) | 100,000 | * | 100,000 | — | — | — | — | — | — | — |
* | less than 1%. |
(1) | Includes 3,735,333 shares of Class A Common Stock, 5,628,000 shares of Class A Common Stock underlying shares of Class C Common Stock, 5,166,667 Private Placement Warrants, each of which entitles the holder to purchase one share of Class A Common Stock, and the 5,166,667 shares of Class A Common Stock issuable upon exercise of such Private Placement Warrants. The members of the Sponsor are Acceleration Capital Management LLC (“ACM”) and Revolution Special Opportunities LLC (“RSO”). John K. Delaney is the managing member of ACM and Stephen M. Case is the managing member of RSO. The members of the Sponsor elect and remove its managers. By virtue of control over our sponsor, each of Mr. Delaney, Mr. Case, RSO and ACM may be deemed to beneficially own shares held by our sponsor. The address of these entities is 1717 Rhode Island Avenue, NW 10th floor, Washington, D.C. 20036. |
(2) | Consists of (a) 33,981,955 shares held by Khosla Ventures Seed B, LP, (b) 1,928,958 shares held by Khosla Ventures Seed B (CF), LP, and (c) 20,657,001 shares held by Khosla Ventures V, LP. Dr. Strohband is a Partner and Managing Director at Khosla Ventures and may be deemed to have beneficial ownership with respect to these shares. The address for these entities is 2128 Sand Hill Road, Menlo Park, CA 94025. |
(3) | Consists of (a) 38,183,023 shares held by New Enterprise Associates 15, L.P. (NEA 15) and (b) 43,598 shares held by NEA Ventures 2016, L.P. (Ven 2016). The shares directly held by NEA 15 are indirectly held by NEA Partners 15, L.P. (NEA Partners 15) the sole general partner of NEA 15, NEA 15 GP, LLC (NEA 15 LLC) the sole general partner of NEA Partners 15 and each of the individual managers of NEA 15 LLC. The individual managers (the Managers) of NEA 15 LLC are Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Joshua Makower, Scott D. Sandell and Peter Sonsini. The shares directly held by Ven 2016 are indirectly held by Karen P. Welsh, the general partner of Ven 2016. NEA Partners 15, NEA 15 LLC and the Managers share voting and dispositive power with regard to the shares held by NEA 15. Karen P. Welsh shares voting and dispositive power with regard to the shares held by Ven 2016. All indirect holders of the above referenced shares disclaim beneficial ownership of all applicable shares, except to the extent of their actual pecuniary interest therein. The address for these entities is 1954 Greenspring Drive, Suite 600, Timonium, MD 21093. |
(4) | Consists of 14,302,523 shares of Class A Common Stock held by Canaan X, L.P. The address for this entity is 285 Riverside Avenue, Suite 250, Westport, CT 06880. |
(5) | Consists of 65,567,317 shares held by SVF II BG (DE) LLC. Entities affiliated with SVF II BG (DE) LLC, whose shares are aggregated for the purposes of reporting ownership information, include SVF II Holdings (DE) L.P., SVF II Aggregator (Jersey) L.P. and SoftBank Vision Fund II-2 L.P (“SoftBank Vision Fund II”). SB Investment Advisers (UK) Limited, or SBIA UK, has been appointed as alternative investment fund manager (“AIFM”) and is exclusively responsible for managing SoftBank Vision Fund II in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK |
Financial Conduct Authority accordingly. As AIFM of SoftBank Vision Fund II, SBIA UK is exclusively responsible for making all final decisions related to the acquisition, structuring, financing, voting and disposal of SoftBank Vision Fund II’s investments, including as held by SVF II BG (DE) LLC. The address for this entity is c/o SB Investment Advisers (US) Inc., 1 Circle Star Way, 2F, San Carlos, CA 94070. |
(6) | The principal business address of the entity is 27 HOSPITAL ROAD, GRAND CAYMAN KY1-9008, CAYMAN ISLANDS. |
(7) | Aaron Cowen is the control person of Suvretta Capital Management, LLC, the investment manager of Suvretta Long Master Fund, Ltd, and the principal business address of the entity is 540 Madison Ave., Floor 7, New York, NY 10022-3213. |
(8) | Aaron Cowen is the control person of Suvretta Capital Management, LLC, the investment manager of Suvretta Master Fund, Ltd., and the principal business address of the entity is 540 Madison Ave., Floor 7, New York, NY 10022-3213. |
(9) | The principal business address of the entity is 1600-10250 101 ST NW, EDMONTON AB T5J 3P4, CANADA. |
(10) | Alyeska Investment Group, L.P., the investment manager of Alyeska Master Fund, L.P. (the “Selling Securityholder”), has voting and investment control of the shares held by the Selling Securityholder. Anand Parekh is the Chief Executive Officer of Alyeska Investment Group, L.P. and may be deemed to be the beneficial owner of such shares. Mr. Parekh, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The registered address of Alyeska Master Fund, L.P. is at c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, South Church Street George Town, Grand Cayman, KY1-1104, Cayman Islands. Alyeska Investment Group, L.P. is located at 77 W. Wacker, Suite 700, Chicago IL 60601. |
(11) | The principal business address of the entity is C/O ANTHANOR CAPITAL, LP, 888 SEVENTH AVENUE, 21ST FLOOR, NEW YORK NY 10019. |
(12) | The principal business address of the entity is C/O ANTHANOR CAPITAL, LP, 888 SEVENTH AVENUE, 21ST FLOOR, NEW YORK NY 10019. |
(13) | The registered holders of the referenced shares to be registered are the following funds and accounts under management by subsidiaries of BlackRock, Inc.: BlackRock Science and Technology Trust; BlackRock Science and Technology Trust II; BlackRock Strategic Income Opportunities Portfolio of BlackRock Funds V; BlackRock Global Allocation Fund, Inc.; BlackRock Global Funds – Global Allocation Fund; BlackRock Global Allocation V.I. Fund of BlackRock Variable Series Funds, Inc.; BlackRock Global Allocation Portfolio of BlackRock Series Fund, Inc.; BlackRock Global Allocation Collective Fund; BlackRock Global Funds – Global Dynamic Equity Fund; BlackRock Capital Allocation Trust; and BlackRock Global Long/Short Credit Fund of BlackRock Funds IV. BlackRock, Inc. is the ultimate parent holding company of such subsidiaries. On behalf of such subsidiaries, the applicable portfolio managers, as managing directors (or in other capacities) of such entities, and/or the applicable investment committee members of such funds and accounts, have voting and investment power over the shares held by the funds and accounts which are the registered holders of the referenced shares. Such portfolio managers and/or investment committee members expressly disclaim beneficial ownership of all shares held by such funds and accounts. The addresses of such funds and accounts, such subsidiaries and such portfolio managers and/or investment committee members are 55 East 52nd Street, New York, NY 10055 and 400 Howard Street, San Francisco CA 94105. Shares shown include only the securities being registered for resale and may not incorporate all shares deemed to be beneficially held by the registered holders or BlackRock, Inc. |
(14) | Andrew Weiss is Manager of WAM GP LLC, which is the general partner of Weiss Asset Management LP, the investment manager of Brookdale Global Opportunity Fund (“BGO”). Andrew Weiss, WAM GP LLC, BGO and Weiss Asset Management LP each disclaim beneficial ownership over the Shares except to the extent of their pecuniary interests therein. The principal business address of this entity is c/o Weiss Asset Management LP, 222 Berkeley St., 16th Floor, Boston, MA 02116. |
(15) | Andrew Weiss is Manager of WAM GP LLC, which is the general partner of Weiss Asset Management LP, the investment manager of Brookdale International Partners, L.P (“BIP”). WAM GP LLC is also the Manager of BIP GP LLC, the general partner of BIP. Andrew Weiss, WAM GP LLC, Weiss Asset Management LP, BIP and BIP GP LLC each disclaim beneficial ownership over the Shares except to the |
extent of their pecuniary interests therein. The principal business address of this entity is c/o Weiss Asset Management LP, 222 Berkeley St., 16th Floor, Boston, MA 02116. |
(16) | The principle business address of the entity is C/O ICONIQ CAPITAL, 394 PACIFIC AVE FL 2, SAN FRANCISCO CA 94111-1715. |
(17) | Steven A. Tananbaum is the Chief Investment Officer of GoldenTree Asset Management LP, the investment advisor to Crown Managed Accounts SPC - Crown/GoldenTree Segregated Portfolio. As a result, Mr. Tananbaum may be deemed to be the beneficial owner of these shares. Notwithstanding the foregoing, Mr. Tananbaum disclaims any such beneficial ownership except to the extent of any pecuniary interest. The principal business address of GoldenTree Asset Management LP is 300 Park Avenue, 21st Floor, New York, New York 10022. |
(18) | Includes 300,000 shares of Class A common stock held by Diameter Master Fund LP (“DMF”). Diameter Capital Partners LP is the investment manager (“Investment Manager”) of DMF and, therefore, has investment and voting power over these shares. Scott Goodwin and Jonathan Lewinsohn, as the sole managing members of the general partner of the Investment Manager, make voting and investment decisions on behalf of the Investment Manager. As a result, the Investment Manager, Mr. Goodwin and Mr. Lewinsohn may be deemed to be the beneficial owners of these shares. Notwithstanding the foregoing, each of Mr. Goodwin and Mr. Lewinsohn disclaim any such beneficial ownership. The business address of Diameter Master Fund LP is 55 Hudson Yards, 29th Floor, New York, NY 10001. |
(19) | Steven A. Tananbaum is the Chief Investment Officer of GoldenTree Asset Management LP, the investment advisor to GoldenTree Asset Management LP, the investment advisor to GoldenTree Master Fund, Ltd. As a result, Mr. Tananbaum may be deemed to be the beneficial owner of these shares. Notwithstanding the foregoing, Mr. Tananbaum disclaims any such beneficial ownership except to the extent of any pecuniary interest. The principal business address of GoldenTree Asset Management LP is 300 Park Avenue, 21st Floor, New York, New York 10022. |
(20) | Steven A. Tananbaum is the Chief Investment Officer of GoldenTree Asset Management LP, the investment advisor to GoldenTree Multi Sector-C LP. As a result, Mr. Tananbaum may be deemed to be the beneficial owner of these shares. Notwithstanding the foregoing, Mr. Tananbaum disclaims any such beneficial ownership except to the extent of any pecuniary interest. The principal business address of GoldenTree Asset Management LP is 300 Park Avenue, 21st Floor, New York, New York 10022. |
(21) | Steven A. Tananbaum is the Chief Investment Officer of GoldenTree Asset Management LP, the investment advisor to GoldenTree V1 Master Fund, LP. As a result, Mr. Tananbaum may be deemed to be the beneficial owner of these shares. Notwithstanding the foregoing, Mr. Tananbaum disclaims any such beneficial ownership except to the extent of any pecuniary interest. The principal business address of GoldenTree Asset Management LP is 300 Park Avenue, 21st Floor, New York, New York 10022. |
(22) | The board of directors of Hedosophia Public Investments Limited comprises Ian Osborne, Iain Stokes, Rob King and Trina Le Noury and each director has shared voting and dispositive power with respect to the securities held by Hedosophia Public Investments Limited. Each of them disclaims beneficial ownership of the securities held by Hedosophia Public Investments Limited. The address of Hedosophia Public Investments Limited is Trafalgar Court, Les Banques, St Peter Port, Guernsey GY1 3QL. |
(23) | Steven A. Tananbaum is the Chief Investment Officer of GoldenTree Asset Management LP, the investment advisor to Ginko Tree, LLC. As a result, Mr. Tananbaum may be deemed to be the beneficial owner of these shares. Notwithstanding the foregoing, Mr. Tananbaum disclaims any such beneficial ownership except to the extent of any pecuniary interest. The principal business address of GoldenTree Asset Management LP is 300 Park Avenue, 21st Floor, New York, New York 10022. |
(24) | Steven A. Tananbaum is the Chief Investment Officer of GoldenTree Asset Management LP, the investment advisor to Guadalupe Fund, LP. As a result, Mr. Tananbaum may be deemed to be the beneficial owner of these shares. Notwithstanding the foregoing, Mr. Tananbaum disclaims any such beneficial ownership except to the extent of any pecuniary interest. The principal business address of GoldenTree Asset Management LP is 300 Park Avenue, 21st Floor, New York, New York 10022. |
(25) | The principal business address of the entity is 399 PARK AVE, NEW YORK NY 10022-4614. |
(26) | Steven A. Tananbaum is the Chief Investment Officer of GoldenTree Asset Management LP, the investment advisor to Louisiana State Employees’ Retirement System. As a result, Mr. Tananbaum may be deemed to |
be the beneficial owner of these shares. Notwithstanding the foregoing, Mr. Tananbaum disclaims any such beneficial ownership except to the extent of any pecuniary interest. The principal business address of GoldenTree Asset Management LP is 300 Park Avenue, 21st Floor, New York, New York 10022. |
(27) | Steven A. Tananbaum is the Chief Investment Officer of GoldenTree Asset Management LP, the investment advisor to MA Multi-Sector Opportunistic Fund, LP. As a result, Mr. Tananbaum may be deemed to be the beneficial owner of these shares. Notwithstanding the foregoing, Mr. Tananbaum disclaims any such beneficial ownership except to the extent of any pecuniary interest. The principal business address of GoldenTree Asset Management LP is 300 Park Avenue, 21st Floor, New York, New York 10022. |
(28) | The principal business address of the entity is C/O MARSHALL WACE LLP, GEORGE HOUSE 131 SLOANE STREET, LONDON SW1X 9AT, UNITED KINGDOM. |
(29) | Moore Capital Management, LP, the investment manager of MMF LT, LLC, has voting and investment control of the shares held by MMF LT, LLC. Mr. Louis M. Bacon controls the general partner of Moore Capital Management, LP and may be deemed the beneficial owner of the shares of the Company held by MMF LT, LLC. Mr. Bacon also is the indirect majority owner of MMF LT, LLC. The address of MMF LT, LLC, Moore Capital Management, LP and Mr. Bacon is 11 Times Square, New York, New York 10036. |
(30) | The principal business address of the entity is C/O MARSHALL WACE LLP, GEORGE HOUSE 131 SLOANE STREET, LONDON SW1X 9AT, UNITED KINGDOM. |
(31) | The principal business address of the entity is C/O MARSHALL WACE LLP, GEORGE HOUSE 131 SLOANE STREET, LONDON SW1X 9AT, UNITED KINGDOM. |
(32) | The principal business address of the entity is C/O MARSHALL WACE LLP, GEORGE HOUSE 131 SLOANE STREET, LONDON SW1X 9AT, UNITED KINGDOM. |
(33) | Benjamin Pass is the Chief Investment Officer of TOMS Capital Investment Management LP, the investment manager of this entity, which has an address of 450 West 14th Street, 13th Floor, New York, NY 10014. |
(34) | The principal business address of the entity is 399 PARK AVE, NEW YORK NY 10022-4614. |
(35) | The principal business address of the entity is 460 PARK AVE FL 19, NEW YORK NY 10022-1827. |
(36) | Steven Trieu is the trustee of the trust. |
(37) | The principal business address of the entity is 657 29TH ST MANHATTAN BEACH CA 90266-2232 |
(38) | Washington Harbour Partners, LP, is the investment advisor of this entity, which has a business address of 1201 Wilson Blvd, Suite 2210, Arlington, VA 22209. |
(39) | XN Exponent Advisors LLC serves as investment manager to XN Exponent Master Fund LP (the “Fund”) and has discretionary authority to make investment decisions and determine how to vote any securities held by the Fund. XN Exponent Advisors LLC is wholly owned by XN LP, a registered investment advisor. The general partner of XN LP is XN Management GP LLC, which is indirectly controlled by Gaurav Kapadia. Mr. Kapadia disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. The principal business address of the entities referenced herein is 412 West 15th Street, 13th Floor, New York, New York 10011. |
(40) | Includes 16,000 shares of Class A Common Stock and 24,000 shares of Class A Common Stock underlying shares of Class C Common Stock. |
(41) | Includes 50,000 shares of Class A Common Stock and 50,000 shares of Class A Common Stock underlying shares of Class C Common Stock. |
• | the provisions regarding the size of our board of directors and the election of directors; |
• | the provisions prohibiting stockholder actions without a meeting; |
• | the provisions regarding calling special meetings of stockholders; |
• | the provisions regarding removal of directors; |
• | the provisions regarding the limited liability of directors of Berkshire Grey; and |
• | the provisions regarding the size and classification of our board of directors and the election of directors not to be governed by Section 203 of the DGCL. |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sale price of Class A Common Stock for any 20-trading days within a30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders (which we refer to as the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described below under “— Anti-Dilution Adjustments |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the “fair market value” of the Class A Common Stock, except as otherwise described below; |
• | if, and only if, the Reference Value (as defined above under “ Redemption of warrants when the price per share of Class A Common Stock equals or exceeds $18.00 |
• | if the Reference Value is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described below under “ —Anti-Dilution Adjustments |
Redemption Date (period to expiration of warrants) | Redemption Fair Market Value of shares of Common Stock | |||||||||||||||||||||||||||||||||||
£ 10.00 | 11.00 | 12.00 | 13.00 | 14.00 | 15.00 | 16.00 | 17.00 | ³ 18.00 | ||||||||||||||||||||||||||||
60 months | 0.261 | 0.281 | 0.297 | 0.311 | 0.324 | 0.337 | 0.348 | 0.358 | 0.361 | |||||||||||||||||||||||||||
57 months | 0.257 | 0.277 | 0.294 | 0.310 | 0.324 | 0.337 | 0.348 | 0.358 | 0.361 | |||||||||||||||||||||||||||
54 months | 0.252 | 0.272 | 0.291 | 0.307 | 0.322 | 0.335 | 0.347 | 0.357 | 0.361 | |||||||||||||||||||||||||||
51 months | 0.246 | 0.268 | 0.287 | 0.304 | 0.320 | 0.333 | 0.346 | 0.357 | 0.361 | |||||||||||||||||||||||||||
48 months | 0.241 | 0.263 | 0.283 | 0.301 | 0.317 | 0.332 | 0.344 | 0.356 | 0.361 | |||||||||||||||||||||||||||
45 months | 0.235 | 0.258 | 0.279 | 0.298 | 0.315 | 0.330 | 0.343 | 0.356 | 0.361 | |||||||||||||||||||||||||||
42 months | 0.228 | 0.252 | 0.274 | 0.294 | 0.312 | 0.328 | 0.342 | 0.355 | 0.361 | |||||||||||||||||||||||||||
39 months | 0.221 | 0.246 | 0.269 | 0.290 | 0.309 | 0.325 | 0.340 | 0.354 | 0.361 | |||||||||||||||||||||||||||
36 months | 0.213 | 0.239 | 0.263 | 0.285 | 0.305 | 0.323 | 0.339 | 0.353 | 0.361 | |||||||||||||||||||||||||||
33 months | 0.205 | 0.232 | 0.257 | 0.280 | 0.301 | 0.320 | 0.337 | 0.352 | 0.361 | |||||||||||||||||||||||||||
30 months | 0.196 | 0.224 | 0.250 | 0.274 | 0.297 | 0.316 | 0.335 | 0.351 | 0.361 | |||||||||||||||||||||||||||
27 months | 0.185 | 0.214 | 0.242 | 0.268 | 0.291 | 0.313 | 0.332 | 0.350 | 0.361 | |||||||||||||||||||||||||||
24 months | 0.173 | 0.204 | 0.233 | 0.260 | 0.285 | 0.308 | 0.329 | 0.348 | 0.361 | |||||||||||||||||||||||||||
21 months | 0.161 | 0.193 | 0.223 | 0.252 | 0.279 | 0.304 | 0.326 | 0.347 | 0.361 | |||||||||||||||||||||||||||
18 months | 0.146 | 0.179 | 0.211 | 0.242 | 0.271 | 0.298 | 0.322 | 0.345 | 0.361 | |||||||||||||||||||||||||||
15 months | 0.130 | 0.164 | 0.197 | 0.230 | 0.262 | 0.291 | 0.317 | 0.342 | 0.361 | |||||||||||||||||||||||||||
12 months | 0.111 | 0.146 | 0.181 | 0.216 | 0.250 | 0.282 | 0.312 | 0.339 | 0.361 | |||||||||||||||||||||||||||
9 months | 0.090 | 0.125 | 0.162 | 0.199 | 0.237 | 0.272 | 0.305 | 0.336 | 0.361 | |||||||||||||||||||||||||||
6 months | 0.065 | 0.099 | 0.137 | 0.178 | 0.219 | 0.259 | 0.296 | 0.331 | 0.361 | |||||||||||||||||||||||||||
3 months | 0.034 | 0.065 | 0.104 | 0.150 | 0.197 | 0.243 | 0.286 | 0.326 | 0.361 | |||||||||||||||||||||||||||
0 months | — | — | 0.042 | 0.115 | 0.179 | 0.233 | 0.281 | 0.323 | 0.361 |
• | 1% of the total number of shares of Class A Common Stock then outstanding; or |
• | the average weekly reported trading volume of Class A Common Stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |
• | the issuer of the securities that was formerly a shell company has ceased to be a shell company; |
• | the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; |
• | the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Current Reports on Form 8-K; and |
• | at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company. |
• | distributions to members, partners, stockholders or other equityholders of the Selling Securityholders; |
• | purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus; |
• | ordinary brokerage transactions and transactions in which the broker solicits purchasers; |
• | block trades in which the broker-dealer so engaged will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction; |
• | an over-the-counter |
• | through trading plans entered into by a Selling Securityholder pursuant to Rule 10b5-1 under the Exchange Act, that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans; |
• | to or through underwriters or broker-dealers; |
• | in “at the market” offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents; |
• | in privately negotiated transactions; |
• | in options transactions; |
• | through a combination of any of the above methods of sale; or |
• | any other method permitted pursuant to applicable law. |
F-2 | ||
Consolidated Financial Statements | ||
F-3 | ||
F-4 | ||
F-5 | ||
F-6 | ||
F-7 – F-30 |
Consolidated Financial Statements | ||
F-31 | ||
F-32 | ||
F-33 | ||
F-34 | ||
F- 35 – F-51 |
F-52 | ||
Financial Statements: | ||
F-53 | ||
F-54 | ||
F-55 | ||
F-56 | ||
F-57 – F-75 |
F-76 | ||
F-77 | ||
F-78 | ||
F-79 | ||
F-80 – F-98 |
December 31, | ||||||||
2020 | 2019 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 93,857 | $ | 159,298 | ||||
Accounts receivable | 16,752 | 565 | ||||||
Inventories | 758 | 403 | ||||||
Deferred fulfillment costs (see Note 7 for related party transactions) | 3,461 | 20,966 | ||||||
Prepaid expenses | 804 | 752 | ||||||
Other current assets | 132 | 229 | ||||||
Total current assets | 115,764 | 182,213 | ||||||
Property and equipment – net | 9,403 | 1,691 | ||||||
Restricted cash | 1,121 | 150 | ||||||
Other non-current assets | 101 | 64 | ||||||
Total assets | $ | 126,389 | $ | 184,118 | ||||
LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS’ DEFICIT | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 1,681 | $ | 1,239 | ||||
Accrued expenses | 7,771 | 4,346 | ||||||
Contract liabilities (see Note 7 for related party transactions) | 22,331 | 30,637 | ||||||
Other current liabilities | 182 | 72 | ||||||
Total current liabilities | 31,965 | 36,294 | ||||||
Warrant liability | — | 3,922 | ||||||
Share-based compensation liability | 3,047 | 350 | ||||||
Other non-current liabilities | 2,057 | 140 | ||||||
Total liabilities | 37,069 | 40,706 | ||||||
Commitments and contingencies (Note 13) | ||||||||
Mezzanine equity: | 0 | 0 | ||||||
Redeemable convertible preferred stock – $0.001 par value; 32,055,463 shares authorized; 28,207,674 shares issued and outstanding at December 31, 2020 and 2019; aggregate liquidation preference of $239,447 as of December 31, 2020 and 2019 (Note 8) | 223,442 | 223,442 | ||||||
Stockholders’ deficit: | ||||||||
Common stock – $0.001 par value; 44,531,024 and 42,000,000 shares authorized, 4,814,981 and 4,713,349 shares issued, and 3,623,109 and 3,521,477 outstanding at December 31, 2020 and 2019, respectively | 3 | 3 | ||||||
Additional paid-in capital | 17,578 | 14,028 | ||||||
Accumulated deficit | (151,704 | ) | (94,061 | ) | ||||
Accumulated other comprehensive income | 1 | — | ||||||
Total stockholders’ deficit | (134,122 | ) | (80,030 | ) | ||||
Total liabilities, mezzanine equity, and stockholders’ deficit | $ | 126,389 | $ | 184,118 | ||||
Years Ended December 31, | ||||||||
2020 | 2019 | |||||||
Revenue (see Note 7 for related party transactions) | $ | 34,835 | $ | 7,972 | ||||
Cost of revenue (see Note 7 for related party transactions) | 32,009 | 9,974 | ||||||
Gross profit (loss) | 2,826 | (2,002 | ) | |||||
Operating expenses: | ||||||||
General and administrative expense | 15,935 | 15,152 | ||||||
Sales and marketing expense | 12,910 | 5,272 | ||||||
Research and development expense | 35,806 | 27,805 | ||||||
Total operating expenses | 64,651 | 48,229 | ||||||
Loss from operations | (61,825 | ) | (50,231 | ) | ||||
Interest income | 280 | 579 | ||||||
Other income | 3,907 | 142 | ||||||
Net loss before income taxes | (57,638 | ) | (49,510 | ) | ||||
Income tax | 5 | 1 | ||||||
Net loss | $ | (57,643 | ) | $ | (49,511 | ) | ||
Other comprehensive income (loss): | ||||||||
Net foreign currency translation adjustments | 1 | — | ||||||
Total comprehensive loss | $ | (57,642 | ) | $ | (49,511 | ) | ||
Net loss per common share – basic and diluted | $ | (16.22 | ) | $ | (17.77 | ) | ||
Weighted average shares outstanding – basic and diluted | 3,554,478 | 2,786,510 |
Mezzanine equity Series A and B | Common stock | Additional paid-in capital | Accumulated deficit | Accumulated other comprehensive income | Total stockholders’ deficit | |||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||
Balance – December 31, 2018 | 18,419,514 | $ | 60,631 | 2,579,180 | $ | — | $ | 1,632 | $ | (44,550 | ) | $ | — | $ | (42,918 | ) | ||||||||||||||||
Issuance of redeemable convertible preferred stock, net of issuance costs of $7,675 | 9,788,160 | 162,811 | — | — | — | — | — | — | ||||||||||||||||||||||||
Proceeds from exercise of stock options | — | — | 942,297 | 3 | 712 | — | — | 715 | ||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 11,684 | — | — | 11,684 | ||||||||||||||||||||||||
Net loss | — | — | — | — | — | (49,511 | ) | — | (49,511 | ) | ||||||||||||||||||||||
Balance – December 31, 2019 | 28,207,674 | $ | 223,442 | 3,521,477 | $ | 3 | $ | 14,028 | $ | (94,061 | ) | $ | — | $ | (80,030 | ) | ||||||||||||||||
Proceeds from exercise of stock options | — | — | 101,632 | — | 226 | — | — | 226 | ||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 3,324 | — | — | 3,324 | ||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | — | — | 1 | 1 | ||||||||||||||||||||||||
Net loss | — | — | — | — | — | (57,643 | ) | — | (57,643 | ) | ||||||||||||||||||||||
Balance – December 31, 2020 | 28,207,674 | $ | 223,442 | 3,623,109 | $ | 3 | $ | 17,578 | $ | (151,704 | ) | $ | 1 | $ | (134,122 | ) | ||||||||||||||||
Years Ended December 31, | ||||||||
2020 | 2019 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net loss | $ | (57,643 | ) | $ | (49,511 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities | ||||||||
Depreciation and amortization | 1,006 | 312 | ||||||
Gain on change in fair value of warrants | (3,922 | ) | (141 | ) | ||||
Gain on foreign currency transactions | 5 | — | ||||||
Stock-based compensation | 6,021 | 12,034 | ||||||
Change in operating assets and liabilities | ||||||||
Accounts receivable | (16,187 | ) | (264 | ) | ||||
Inventories | (355 | ) | (245 | ) | ||||
Deferred fulfillment costs | 17,505 | (2,992 | ) | |||||
Prepaid expenses and other assets | 8 | (335 | ) | |||||
Accounts payable | 442 | (1,713 | ) | |||||
Accrued expenses | 3,425 | 4,002 | ||||||
Contract liabilities | (8,306 | ) | 9,921 | |||||
Other liabilities | 2,027 | 111 | ||||||
Net cash used in operating activities | (55,974 | ) | (28,821 | ) | ||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Capital expenditures | (8,718 | ) | (1,818 | ) | ||||
Net cash used in investing activities | (8,718 | ) | (1,818 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Proceeds from exercise of stock options | 226 | 715 | ||||||
Proceeds from the issuance of Series B-2 Preferred Stock, net of issuance costs | — | 162,811 | ||||||
Proceeds from the issuance of Series B-3 Warrants, net of issuance costs | — | 4,063 | ||||||
Net cash provided by financing activities | 226 | 167,589 | ||||||
Effect of exchange rate on cash | (4 | ) | — | |||||
Net (decrease) increase in cash, cash equivalents, and restricted cash | (64,470 | ) | 136,950 | |||||
Cash, cash equivalents, and restricted cash at beginning of period | 159,448 | 22,498 | ||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 94,978 | $ | 159,448 | ||||
December 31, | ||||||||
2020 | 2019 | |||||||
(in thousands) | ||||||||
Cash | $ | 999 | $ | 157 | ||||
Money Market funds in Cash and Cash Equivalents | 92,858 | 159,141 | ||||||
Restricted cash | 1,121 | 150 | ||||||
Cash, cash equivalents, and restricted cash | $ | 94,978 | $ | 159,448 | ||||
• | Contract with the customer is identified; |
• | Performance obligations in the contract is identified; |
• | Transaction price is determined; |
• | Transaction price is allocated to the performance obligations; and |
• | When performance obligations are satisfied (see Note 6 for additional information). |
Level 1 — | Quoted prices for identical assets and liabilities traded in active exchange markets. | |||
Level 2 — | Observable inputs other than Level 1 that are directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities inactive markets, or other observable inputs that can be corroborated by observable market data. | |||
Level 3 — | Unobservable inputs supported by little or no market activity for financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. |
December 31, | ||||||||
2020 | 2019 | |||||||
(in thousands) | ||||||||
Leasehold improvements | $ | 5,907 | $ | 333 | ||||
Machinery and equipment | 15 | 10 | ||||||
Furniture and fixtures | 714 | 158 | ||||||
Research and development equipment | 2,794 | 1,030 | ||||||
Computer hardware and software | 1,219 | 365 | ||||||
Construction in progress | 437 | 472 | ||||||
Subtotal | 11,086 | 2,368 | ||||||
Less: Accumulated depreciation | 1,683 | 677 | ||||||
Property and equipment, net | $ | 9,403 | $ | 1,691 | ||||
December 31, | ||||||||
2020 | 2019 | |||||||
(in thousands) | ||||||||
Accrued compensation | $ | 5,424 | $ | 3,056 | ||||
Accrued sales taxes payable | 879 | 142 | ||||||
Accrued professional services | 754 | 0 | ||||||
Accrued materials | 401 | 290 | ||||||
Accrued other | 272 | 541 | ||||||
Accrued warranty | 41 | 317 | ||||||
$ | 7,771 | $ | 4,346 | |||||
December 31, | ||||||||
2020 | 2019 | |||||||
(in thousands) | ||||||||
Beginning balance | $ | 317 | $ | 0 | ||||
Accrual (reversal) for warranty expense | (136 | ) | 449 | |||||
Warranty costs incurred during period | (140 | ) | (132 | ) | ||||
Ending balance | $ | 41 | $ | 317 | ||||
Years Ended December 31, | ||||||||
2020 | 2019 | |||||||
(in thousands) | ||||||||
Transferred over time | $ | 10,045 | $ | 7,872 | ||||
Transferred at a point in time | 24,790 | 100 | ||||||
Total Revenue | $ | 34,835 | $ | 7,972 | ||||
Contract Liabilities | ||||
(in thousands) | ||||
Contract liabilities at December 31, 2018 | $ | 20,716 | ||
Additions to contract liabilities during the period | 17,790 | |||
Revenue recognized in the period from: | ||||
Amounts included in contract liabilities at the beginning of the period | (2,111 | ) | ||
Amounts added to contract liabilities during the period | (5,758 | ) | ||
Contract liabilities at December 31, 2019 | 30,637 | |||
Additions to contract liabilities during the period | 26,398 | |||
Revenue recognized in the period from: | ||||
Amounts included in contract liabilities at the beginning of the period | (29,743 | ) | ||
Amounts added to contract liabilities during the period | (4,961 | ) | ||
Contract liabilities at December 31, 2020 | $ | 22,331 | ||
December 31, 2020 and 2019 | ||||||||||||
Convertible preferred stock | ||||||||||||
Authorized shares | Shares issued and outstanding | Liquidation preference | ||||||||||
(in thousands) | ||||||||||||
Series A | 2,212,389 | 2,212,389 | $ | 500 | ||||||||
Series A-1 | 2,403,846 | 2,403,846 | 2,500 | |||||||||
Series A-2 | 4,118,126 | 4,118,126 | 11,098 | |||||||||
Series A-3 | 785,056 | 785,056 | 1,058 | |||||||||
Series A-4 | 710,321 | 710,321 | 1,531 | |||||||||
Series B | 5,385,474 | 5,385,474 | 24,100 | |||||||||
Series B-1 | 2,804,302 | 2,804,302 | 24,110 | |||||||||
Series B-2 | 11,732,302 | 9,788,160 | 174,550 | |||||||||
Series B-3 | 1,903,647 | — | — | |||||||||
32,055,463 | 28,207,674 | $ | 239,447 | |||||||||
Years Ended December 31, | ||||||||
2020 | 2019 | |||||||
(in thousands) | ||||||||
Cost of sales | $ | 137 | $ | 475 | ||||
General and administrative | 3,245 | 5,518 | ||||||
Sales and marketing | 1,583 | 897 | ||||||
Research and development | 1,056 | 5,144 | ||||||
Total | $ | 6,021 | $ | 12,034 | ||||
Years Ended December 31, | ||||||||
2020 | 2019 | |||||||
Weighted average expected volatility | 55.0 | % | 55.0 | % | ||||
Weighted average expected term (in years) | 6.1 | 6.1 | ||||||
Weighted average risk-free interest rate | 0.57 | % | 2.00 | % | ||||
Expected dividend yield | 0 | % | 0 | % |
Options | Weighted-Average Exercise Price | Weighted-Average Remaining Contractual Term (years) | ||||||||||
Outstanding at December 31, 2018 | 3,513,759 | $ | 1.25 | 7.9 | ||||||||
Granted | 1,077,900 | 7.04 | ||||||||||
Exercised | 942,297 | 0.76 | ||||||||||
Forfeited | 140,148 | 3.07 | ||||||||||
Outstanding at December 31, 2019 | 3,509,214 | $ | 3.09 | 7.8 | ||||||||
Granted | 2,957,409 | 6.70 | ||||||||||
Exercised | 101,632 | 2.22 | ||||||||||
Forfeited | 412,654 | 5.99 | ||||||||||
Outstanding at December 31, 2020 | 5,952,337 | $ | 4.70 | 8.0 | ||||||||
Exercisable at December 31, 2020 | 2,086,639 | $ | 1.91 | 5.6 | ||||||||
Vested or expected to vest at December 31, 2020 | 5,952,337 | $ | 4.70 | 8.0 | ||||||||
December 31, 2020 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
(in thousands) | ||||||||||||||||
Assets | ||||||||||||||||
Money Market funds in Cash and Cash Equivalents | $ | 92,858 | $ | — | $ | — | $ | 92,858 | ||||||||
Total Assets | $ | 92,858 | $ | — | $ | — | $ | 92,858 | ||||||||
Liabilities: | ||||||||||||||||
Restricted Stock | $ | — | $ | — | $ | 3,047 | $ | 3,047 | ||||||||
Warrants | — | — | — | — | ||||||||||||
Total Liabilities | $ | — | $ | — | $ | 3,047 | $ | 3,047 | ||||||||
December 31, 2019 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
(in thousands) | ||||||||||||||||
Assets | ||||||||||||||||
Money Market funds in Cash and Cash Equivalents | $ | 159,141 | $ | — | $ | — | $ | 159,141 | ||||||||
Total Assets | $ | 159,141 | $ | — | $ | — | $ | 159,141 | ||||||||
Liabilities: | ||||||||||||||||
Restricted Stock | $ | — �� | $ | — | $ | 350 | $ | 350 | ||||||||
Warrants | — | — | 3,922 | 3,922 | ||||||||||||
Total Liabilities | $ | — | $ | — | $ | 4,272 | $ | 4,272 | ||||||||
Warrants | ||||
(in thousands) | ||||
Balance at December 31, 2018 | $ | 0 | ||
Issuance of Series B-3 Preferred Stock Warrants | 4,063 | |||
Change in fair value | (141 | ) | ||
Balance at December 31, 2019 | 3,922 | |||
Change in fair value | (3,922 | ) | ||
Balance at December 31, 2020 | $ | 0 | ||
2019 | ||||
Fair Value of the underlying Instrument | $ | 4.19 – $4.43 | ||
Time to liquidity event (in years) | 3.0 | |||
Average volatility rate | 55.0 | % | ||
Risk-free interest rate | 1.62 | % |
Restricted Stock | ||||
(in thousands) | ||||
Balance at December 31, 2018 | $ | 0 | ||
Issuance of Restricted Stock | 350 | |||
Change in fair value | 0 | |||
Balance at December 31, 2019 | 350 | |||
Change relating to vesting at original issuance price | 2,098 | |||
Change in fair value | 599 | |||
Balance at December 31, 2020 | $ | 3,047 | ||
Years Ended December 31, | ||||||||
2020 | 2019 | |||||||
Fair Value of the underlying Instrument | $ | 6.70 – $13.01 | $ | 8.32 | ||||
Exercise Price | $ | 9.23 – $9.48 | $ | 9.23 – $9.34 | ||||
Time to liquidity event (in years) | 5.6 – 7.1 | 5.6 – 6.3 | ||||||
Average volatility rate | 55.0 | % | 55.0 | % | ||||
Risk-free interest rate | 0.28 – 0.93 | % | 1.69 – 1.72 | % |
Years Ended December 31, | ||||||||
2020 | 2019 | |||||||
(in thousands) | ||||||||
Domestic | $ | (57,683 | ) | $ | (49,510 | ) | ||
Foreign | 45 | — | ||||||
Total | $ | (57,638 | ) | $ | (49,510 | ) | ||
Years Ended December 31, | ||||||||
2020 | 2019 | |||||||
Federal statutory rate | 21.0 | % | 21.0 | % | ||||
State rate, net of federal benefit | 4.1 | % | 4.7 | % | ||||
Change in valuation allowance | (30.0 | )% | (33.6 | )% | ||||
Tax credits generated | 5.9 | % | 6.5 | % | ||||
Stock-based compensation | (2.1 | )% | 1.6 | % | ||||
Warrant revaluation | 1.4 | % | 0.1 | % | ||||
Permanent differences | (0.2 | )% | (0.3 | )% | ||||
Effective tax rate | 0.0 | % | 0.0 | % | ||||
Years Ended December 31, | ||||||||
2020 | 2019 | |||||||
(in thousands) | ||||||||
Federal and state net operating carryforwards | $ | 36,988 | $ | 23,277 | ||||
Research and development and other credits | 8,000 | 4,658 | ||||||
Stock-based compensation | 240 | 233 | ||||||
Deferred revenue | 228 | 95 | ||||||
Other | 1,262 | 1,166 | ||||||
Gross deferred tax assets | 46,718 | 29,429 | ||||||
Valuation allowance | (46,722 | ) | (29,429 | ) | ||||
Net deferred tax assets | $ | (4 | ) | $ | 0— | |||
Years Ended December 31, | ||||||||
2020 | 2019 | |||||||
(in thousands) | ||||||||
United States | $ | 25,020 | $ | 3,193 | ||||
Japan | 9,815 | 4,779 | ||||||
Total Revenue | $ | 34,835 | $ | 7,972 | ||||
Operating Leases | ||||
Years Ending December 31, | (in thousands) | |||
2021 | $ | 2,020 | ||
2022 | 1,601 | |||
2023 | 1,462 | |||
2024 | 1,504 | |||
2025 | 1,473 | |||
Thereafter | 7,079 | |||
$ | 15,139 | |||
June 30, | December 31, | |||||||
2021 | 2020 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 52,830 | $ | 93,857 | ||||
Accounts receivable | 2,669 | 16,752 | ||||||
Inventories, net | 2,719 | 758 | ||||||
Deferred fulfillment costs (see Note 7 for related party transactions) | 13,373 | 3,461 | ||||||
Prepaid expenses | 2,537 | 804 | ||||||
Other current assets | 2,091 | 132 | ||||||
Total current assets | 76,219 | 115,764 | ||||||
Property and equipment – net | 10,466 | 9,403 | ||||||
Restricted cash | 1,121 | 1,121 | ||||||
Deferred transaction costs | 1,770 | — | ||||||
Other non-current assets | 24 | 101 | ||||||
Total assets | $ | 89,600 | $ | 126,389 | ||||
LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS’ DEFICIT | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 5,412 | $ | 1,681 | ||||
Accrued expenses | 12,339 | 7,771 | ||||||
Contract liabilities (see Note 7 for related party transactions) | 23,765 | 22,331 | ||||||
Other current liabilities | 181 | 182 | ||||||
Total current liabilities | 41,697 | 31,965 | ||||||
Share-based compensation liability | 21,371 | 3,047 | ||||||
Other non-current liabilities | 1,996 | 2,057 | ||||||
Total liabilities | 65,064 | 37,069 | ||||||
Commitments and contingencies (Note 13) | 0 | 0 | ||||||
Mezzanine equity: | ||||||||
Redeemable convertible preferred stock – $0.001 par value; 32,055,463 shares authorized; 28,207,674 shares issued and outstanding at June 30, 2021 and December 31, 2020; aggregate liquidation preference of $239,447 as of June 30, 2021 and December 31, 2020 (Note 8) | 223,442 | 223,442 | ||||||
Stockholders’ deficit: | ||||||||
Common stock – $0.001 par value; 44,531,024 shares authorized, 4,814,981 shares issued, and 3,895,473 and 3,623,109 shares outstanding as of June 30, 2021 and December 31, 2020, respectively | 3 | 3 | ||||||
Additional paid-in capital | 29,237 | 17,578 | ||||||
Accumulated deficit | (228,141 | ) | (151,704 | ) | ||||
Accumulated other comprehensive income (loss) | (5 | ) | 1 | |||||
Total stockholders’ deficit | (198,906 | ) | (134,122 | ) | ||||
Total liabilities, mezzanine equity, and stockholders’ deficit | $ | 89,600 | $ | 126,389 | ||||
For the Three Months Ended June 30, | For the Six Months Ended June 30, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
Revenue (see Note 7 for related party transactions) | $ | 4,503 | $ | 2,752 | $ | 8,468 | $ | 29,028 | ||||||||
Cost of revenue (see Note 7 for related party transactions) | 5,240 | 2,658 | 9,938 | 27,392 | ||||||||||||
Gross (loss) profit | (737 | ) | 94 | (1,470 | ) | 1,636 | ||||||||||
Operating expenses: | ||||||||||||||||
General and administrative expense | 4,710 | 2,877 | 8,853 | 6,722 | ||||||||||||
Sales and marketing expense | 10,540 | 1,667 | 38,023 | 3,338 | ||||||||||||
Research and development expense | 15,741 | 9,163 | 28,051 | 17,200 | ||||||||||||
Total operating expenses | 30,991 | 13,707 | 74,927 | 27,260 | ||||||||||||
Loss from operations | (31,728 | ) | (13,613 | ) | (76,397 | ) | (25,624 | ) | ||||||||
Interest income, net | 3 | 8 | 14 | 273 | ||||||||||||
Other (expense) income, net | (22 | ) | 3,922 | (42 | ) | 3,926 | ||||||||||
Net loss before income taxes | (31,747 | ) | (9,683 | ) | (76,425 | ) | (21,425 | ) | ||||||||
Income tax | 7 | — | 12 | — | ||||||||||||
Net loss | $ | (31,754 | ) | $ | (9,683 | ) | $ | (76,437 | ) | $ | (21,425 | ) | ||||
Other comprehensive loss: | ||||||||||||||||
Net foreign currency translation adjustments | — | — | (6 | ) | — | |||||||||||
Total comprehensive loss | $ | (31,754 | ) | $ | (9,683 | ) | $ | (76,443 | ) | $ | (21,425 | ) | ||||
Net loss per common share – basic and diluted | $ | (8.21 | ) | $ | (2.74 | ) | $ | (20.21 | ) | $ | (6.07 | ) | ||||
Weighted average shares outstanding – basic and diluted | 3,868,554 | 3,532,100 | 3,781,658 | 3,528,301 |
Mezzanine equity Series A and B | Common stock | Additional paid-in | Accumulated | Accumulated other comprehensive | Total stockholders’ | |||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | capital | deficit | income (loss) | deficit | |||||||||||||||||||||||||
Balance – December 31, 2020 | 28,207,674 | $ | 223,442 | 3,623,109 | $ | 3 | $ | 17,578 | $ | (151,704 | ) | $ | 1 | $ | (134,122 | ) | ||||||||||||||||
Proceeds from exercise of stock options | — | — | 229,281 | — | 278 | — | — | 278 | ||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 1,165 | — | — | 1,165 | ||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | — | — | (6 | ) | (6 | ) | ||||||||||||||||||||||
Net loss | — | — | — | — | — | (44,683 | ) | — | (44,683 | ) | ||||||||||||||||||||||
Balance – March 31, 2021 | 28,207,674 | $ | 223,442 | 3,852,390 | $ | 3 | $ | 19,021 | $ | (196,387 | ) | $ | (5 | ) | $ | (177,368 | ) | |||||||||||||||
�� | ||||||||||||||||||||||||||||||||
Proceeds from exercise of stock options | — | — | 43,083 | — | 217 | — | — | 217 | ||||||||||||||||||||||||
Reclassification of restricted stock to equity | 8,836 | 8,836 | ||||||||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 1,163 | — | — | 1,163 | ||||||||||||||||||||||||
Net loss | — | — | — | — | — | (31,754 | ) | — | (31,754 | ) | ||||||||||||||||||||||
Balance – June 30, 2021 | 28,207,674 | $ | 223,442 | 3,895,473 | $ | 3 | $ | 29,237 | $ | (228,141 | ) | $ | (5 | ) | $ | (198,906 | ) | |||||||||||||||
Balance – December 31, 2019 | 28,207,674 | $ | 223,442 | 3,521,477 | $ | 3 | $ | 14,028 | $ | (94,061 | ) | $ | — | $ | (80,030 | ) | ||||||||||||||||
Proceeds from exercise of stock options | — | — | — | — | 32 | — | — | 32 | ||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 461 | — | — | 461 | ||||||||||||||||||||||||
Net loss | — | — | — | — | — | (11,742 | ) | — | (11,742 | ) | ||||||||||||||||||||||
Balance – March 31, 2020 | 28,207,674 | $ | 223,442 | 3,521,477 | $ | 3 | $ | 14,521 | $ | (105,803 | ) | $ | — | $ | (91,279 | ) | ||||||||||||||||
Proceeds from exercise of stock options | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||
Stock-based compensation | — | — | — | — | 361 | — | — | 361 | ||||||||||||||||||||||||
Net loss | — | — | — | — | — | (9,683 | ) | — | (9,683 | ) | ||||||||||||||||||||||
Balance – June 30, 2020 | 28,207,674 | $ | 223,442 | 3,521,477 | $ | 3 | $ | 14,882 | $ | (115,486 | ) | $ | — | $ | (100,601 | ) | ||||||||||||||||
Six Months Ended June 30, | ||||||||
2021 | 2020 | |||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
Net loss | $ | (76,437 | ) | $ | (21,425 | ) | ||
Adjustments to reconcile net loss to net cash used in operating activities | ||||||||
Depreciation and amortization | 1,217 | 158 | ||||||
Loss on disposal of fixed assets | 15 | — | ||||||
Gain on change in fair value of warrants | — | (3,921 | ) | |||||
Gain on foreign currency transactions | 37 | — | ||||||
Stock-based compensation | 29,488 | 1,259 | ||||||
Change in operating assets and liabilities | ||||||||
Accounts receivable | 14,083 | (2,914 | ) | |||||
Inventories | (1,961 | ) | (444 | ) | ||||
Deferred fulfillment costs | (9,912 | ) | 17,693 | |||||
Prepaid expenses and other assets | (3,729 | ) | (215 | ) | ||||
Accounts payable | 3,621 | (235 | ) | |||||
Accrued expenses | 2,866 | (538 | ) | |||||
Contract liabilities | 1,434 | (25,195 | ) | |||||
Other liabilities | (62 | ) | 261 | |||||
Net cash used in operating activities | (39,340 | ) | (35,516 | ) | ||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
Capital expenditures | (2,139 | ) | (2,114 | ) | ||||
Net cash used in investing activities | (2,139 | ) | (2,114 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
Proceeds from exercise of stock options | 495 | 32 | ||||||
Net cash provided by financing activities | 495 | 32 | ||||||
Effect of exchange rate on cash | (43 | ) | — | |||||
Net decrease in cash, cash equivalents, and restricted cash | (41,027 | ) | (37,598 | ) | ||||
Cash, cash equivalents, and restricted cash at beginning of period | 94,978 | 159,448 | ||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 53,951 | $ | 121,850 | ||||
NON-CASH INVESTING AND FINANCING ACTIVITIES | ||||||||
Purchase of property and equipment included in accounts payable and accrued expenses | $ | 156 | $ | 1,127 | ||||
Deferred transaction costs not yet paid included in accrued expenses | $ | 1,656 | $ | — | ||||
June 30, | June 30, | |||||||
2021 | 2020 | |||||||
(in thousands) | ||||||||
Cash | $ | 1,334 | $ | 2,578 | ||||
Money Market funds in Cash and Cash Equivalents | 51,496 | 118,151 | ||||||
Restricted cash | 1,121 | 1,121 | ||||||
Cash, cash equivalents, and restricted cash | $ | 53,951 | $ | 121,850 | ||||
June 30, | December 31, | |||||||
2021 | 2020 | |||||||
(in thousands) | ||||||||
Work in progress | $ | 13 | $ | 3 | ||||
Finished goods | 2,706 | 755 | ||||||
Inventory, net | $ | 2,719 | $ | 758 | ||||
June 30, | December 31, | |||||||
2021 | 2020 | |||||||
(in thousands) | ||||||||
Leasehold improvements | $ | 6,224 | $ | 5,907 | ||||
Machinery and equipment | 10 | 15 | ||||||
Furniture and fixtures | 784 | 714 | ||||||
Research and development equipment | 4,679 | 2,794 | ||||||
Computer hardware and software | 1,513 | 1,219 | ||||||
Construction in progress | 93 | 437 | ||||||
Subtotal | 13,303 | 11,086 | ||||||
Less: Accumulated depreciation | 2,837 | 1,683 | ||||||
Property and equipment, net | $ | 10,466 | $ | 9,403 | ||||
June 30, | December 31, | |||||||
2021 | 2020 | |||||||
(in thousands) | ||||||||
Accrued compensation | $ | 3,871 | $ | 5,424 | ||||
Accrued sales taxes payable | 185 | 879 | ||||||
Accrued professional services | 2,045 | 754 | ||||||
Accrued materials | 4,077 | 401 | ||||||
Accrued other | 2,049 | 272 | ||||||
Accrued warranty | 112 | 41 | ||||||
Accrued expenses | $ | 12,339 | $ | 7,771 | ||||
June 30, | December 31, | |||||||
2021 | 2020 | |||||||
(in thousands) | ||||||||
Beginning balance | $ | 41 | $ | 317 | ||||
Accrual (reversal) for warranty expense | 107 | (136 | ) | |||||
Warranty costs incurred during period | (36 | ) | (140 | ) | ||||
Ending balance | $ | 112 | $ | 41 | ||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
(in thousands) | (in thousands) | |||||||||||||||
Transferred over time | $ | 4,275 | $ | 2,535 | $ | 8,211 | $ | 6,465 | ||||||||
Transferred at a point in time | 228 | 217 | 257 | 22,563 | ||||||||||||
Total revenue | $ | 4,503 | $ | 2,752 | $ | 8,468 | $ | 29,028 | ||||||||
Contract Liabilities | ||||
(in thousands) | ||||
Contract liabilities at December 31, 2020 | $ | 22,331 | ||
Additions to contract liabilities during the period | 9,728 | |||
Revenue recognized in the period from: | ||||
Amounts included in contract liabilities at the beginning of the period | (7,084 | ) | ||
Amounts added to contract liabilities during the period | (1,210 | ) | ||
Contract liabilities at June 30, 2021 | $ | 23,765 | ||
June 30, 2021 and December 31, 2020 | ||||||||||||
Convertible preferred stock | ||||||||||||
Authorized shares | Shares issued and outstanding | Liquidation preference | ||||||||||
Series A | 2,212,389 | 2,212,389 | $ | 500 | ||||||||
Series A-1 | 2,403,846 | 2,403,846 | 2,500 | |||||||||
Series A-2 | 4,118,126 | 4,118,126 | 11,098 | |||||||||
Series A-3 | 785,056 | 785,056 | 1,058 | |||||||||
Series A-4 | 710,321 | 710,321 | 1,531 | |||||||||
Series B | 5,385,474 | 5,385,474 | 24,100 | |||||||||
Series B-1 | 2,804,302 | 2,804,302 | 24,110 | |||||||||
Series B-2 | 11,732,302 | 9,788,160 | 174,550 | |||||||||
Series B-3 | 1,903,647 | — | — | |||||||||
32,055,463 | 28,207,674 | $ | 239,447 | |||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
(in thousands) | (in thousands) | |||||||||||||||
Cost of sales | $ | 35 | $ | 28 | $ | 70 | $ | 56 | ||||||||
General and administrative | 430 | (17 | ) | 856 | 494 | |||||||||||
Sales and marketing | 4,549 | 65 | 27,961 | 233 | ||||||||||||
Research and development | 295 | 240 | 601 | 476 | ||||||||||||
Total | $ | 5,309 | $ | 316 | $ | 29,488 | $ | 1,259 | ||||||||
Options | Weighted- Average Exercise Price | Weighted- Average Remaining Contractual Term (years) | ||||||||||
Outstanding at December 31, 2020 | 5,956,837 | $ | 4.70 | 8.0 | ||||||||
Exercised | 272,364 | 1.82 | 2.9 | |||||||||
Cancelled | 4,596 | 3.65 | — | |||||||||
Forfeited | 59,055 | 3.59 | — | |||||||||
Outstanding at June 30, 2021 | 5,620,822 | $ | 4.85 | 7.8 | ||||||||
Exercisable at June 30, 2021 | 2,342,488 | $ | 2.71 | 6.1 | ||||||||
Vested or expected to vest at June 30, 2021 | 5,620,822 | $ | 4.85 | 7.8 | ||||||||
June 30, 2021 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
(in thousands) | ||||||||||||||||
Assets | ||||||||||||||||
Money Market funds in Cash and Cash Equivalents | $ | 51,496 | $ | — | $ | — | $ | 51,496 | ||||||||
Total Assets | $ | 51,496 | $ | — | $ | — | $ | 51,496 | ||||||||
Liabilities | ||||||||||||||||
Restricted Stock | $ | — | $ | — | $ | 21,371 | $ | 21,371 | ||||||||
Total Liabilities | $ | — | $ | — | $ | 21,371 | $ | 21,371 | ||||||||
December 31, 2020 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
(in thousands) | ||||||||||||||||
Assets | ||||||||||||||||
Money Market funds in Cash and Cash Equivalents | $ | 92,858 | $ | — | $ | — | $ | 92,858 | ||||||||
Total Assets | $ | 92,858 | $ | — | $ | — | $ | 92,858 | ||||||||
Liabilities | ||||||||||||||||
Restricted Stock | $ | — | $ | — | $ | 3,047 | $ | 3,047 | ||||||||
Total Liabilities | $ | — | $ | — | $ | 3,047 | $ | 3,047 | ||||||||
Restricted Stock | ||||
(in thousands) | ||||
Balance at December 31, 2020 | $ | 3,047 | ||
Change relating to vesting at original issuance price | 775 | |||
Change in fair value | 26,385 | |||
Reclassification of restricted stock to equity (see Note 9) | (8,836 | ) | ||
Balance at June 30, 2021 | 21,371 | |||
June 30, | December 31, | |||
2021 | 2020 | |||
Fair Value of the underlying Instrument | $58.60 | $6.70 - 13.01 | ||
Exercise Price | $9.31 - $9.48 | $9.23 - $9.48 | ||
Time to liquidity event (in years) | 6.1 - 7.1 | 5.6 - 7.1 | ||
Average volatility rate | 55.0% | 55.0% | ||
Risk-free interest rate | 0.93% - 1.27% | 0.28% - 0.93% |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2021 | 2020 | 2021 | 2020 | |||||||||||||
(in thousands) | (in thousands) | |||||||||||||||
United States | $ | 2,929 | $ | 292 | $ | 5,334 | $ | 22,792 | ||||||||
Japan | 1,574 | 2,460 | 3,134 | 6,236 | ||||||||||||
Total revenue | $ | 4,503 | $ | 2,752 | $ | 8,468 | $ | 29,028 | ||||||||
Operating Leases | ||||
(in thousands) | ||||
Remainder of 2021 | $ | 1,052 | ||
2022 | 1,601 | |||
2023 | 1,462 | |||
2024 | 1,504 | |||
2025 | 1,473 | |||
Thereafter | 7,079 | |||
$ | 14,171 | |||
ASSETS | ||||
Current Assets | ||||
Cash and cash equivalents | $ | 780,292 | ||
Prepaid expenses | 747,842 | |||
Total Current Assets | 1,528,134 | |||
Cash and marketable securities held in Trust Account | 287,491,254 | |||
TOTAL ASSETS | $ | 289,019,388 | ||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
Current liabilities – accrued expenses | $ | 106,477 | ||
Warrant liability | 22,862,501 | |||
Deferred underwriting payable | 10,062,500 | |||
Total Liabilities | 33,031,478 | |||
Commitments | ||||
Class A common stock subject to possible redemption 25,098,791 shares at redemption value | 250,987,908 | |||
Stockholders’ Equity | ||||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding | — | |||
Class A common stock, $0.0001 par value; 75,000,000 shares authorized; 3,651,209 issued and outstanding (excluding 25,098,791 shares subject to possible redemption) | 365 | |||
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 3,833,333 shares issued and outstanding | 383 | |||
Class C common stock, $0.0001 par value; 15,000,000 shares authorized; 5,750,000 shares issued and outstanding | 575 | |||
Additional paid-in capital | 6,650,386 | |||
Accumulated deficit | (1,651,707 | ) | ||
Total Stockholders’ Equity | 5,000,002 | |||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 289,019,388 | ||
Formation and operating costs | $ | 172,935 | ||
Loss from operations | (172,935 | ) | ||
Other income (expense): | ||||
Interest income – bank | 6 | |||
Interest earned on marketable securities held in Trust Account | 7,721 | |||
Change in fair value of warrant liability | (590,001 | ) | ||
Transaction costs | (828,364 | ) | ||
Compensation expense | (51,667 | ) | ||
Unrealized loss on marketable securities held in Trust Account | (16,467 | ) | ||
Other expense, net | (1,478,772 | ) | ||
Net loss | $ | (1,651,707 | ) | |
Basic and diluted weighted average shares outstanding, Common stock subject to possible redemption | 25,175,858 | |||
Basic and diluted net loss per share, Common stock subject to possible redemption | $ | 0.00 | ||
Basic and diluted weighted average shares outstanding, Non-redeemable common stock | 9,280,127 | |||
Basic and diluted net loss per share, Non-redeemable common stock | $ | (0.18 | ) | |
Class A Common Stock | Class B Common Stock | Class C Common Stock | Additional Paid-in Capital | Accumulated Deficit | Total Stockholders’ Equity | |||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||||
Balance – September 10, 2020 (Inception) | — | $ | — | — | $ | — | — | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||||||
Issuance of Class B common stock to Sponsor | — | — | 8,625,000 | 862 | — | — | 24,138 | — | 25,000 | |||||||||||||||||||||||||||
Cancellation of Class B common stock | — | — | (4,791,667 | ) | (479 | ) | — | — | 479 | — | — | |||||||||||||||||||||||||
Issuance of Class C common stock to Sponsor | — | — | — | — | 5,750,000 | 575 | (575 | ) | — | — | ||||||||||||||||||||||||||
Sale of 28,750,000 Units, net of underwriting discounts | 28,750,000 | 2,875 | — | — | — | — | 257,611,742 | — | 257,614,617 | |||||||||||||||||||||||||||
Class A common stock subject to possible redemption | (25,098,791 | ) | (2,510 | ) | — | — | — | — | (250,985,398 | ) | — | (250,987,908 | ) | |||||||||||||||||||||||
Net loss | — | — | — | — | — | — | — | (1,651,707 | ) | (1,651,707 | ) | |||||||||||||||||||||||||
Balance – December 31, 2020 | 3,651,209 | $ | 365 | 3,833,333 | $ | 383 | 5,750,000 | $ | 575 | $ | 6,650,386 | $ | (1,651,707 | ) | $ | 5,000,002 | ||||||||||||||||||||
Cash Flows from Operating Activities: | ||||
Net loss | $ | (1,651,707 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||
Interest earned on marketable securities held in Trust Account | (7,721 | ) | ||
Change in fair value of warrant liability | 590,001 | |||
Transaction costs | 828,364 | |||
Compensation expense | 51,667 | |||
Unrealized loss on marketable securities held in Trust Account | 16,467 | |||
Changes in operating assets and liabilities: | ||||
Prepaid expenses | (747,842 | ) | ||
Accrued expenses | 106,477 | |||
Net cash used in operating activities | (814,294 | ) | ||
Cash Flows from Investing Activities: | ||||
Investment of cash in Trust Account | (287,500,000 | ) | ||
Net cash used in investing activities | (287,500,000 | ) | ||
Cash Flows from Financing Activities: | ||||
Proceeds from sale of Units, net of underwriting discounts paid | 281,750,000 | |||
Proceeds from sale of Private Placement Warrants | 7,750,000 | |||
Proceeds from promissory note – related party | 88,686 | |||
Repayment of promissory note – related party | (88,686 | ) | ||
Payment of offering costs | (405,414 | ) | ||
Net cash provided by financing activities | 289,094,586 | |||
Net Change in Cash and Cash Equivalents | 780,292 | |||
Cash and Cash Equivalents – Beginning of period | — | |||
Cash and Cash Equivalents – End of period | $ | 780,292 | ||
Non-Cash investing and financing activities: | ||||
Initial classification of Class A common stock subject to possible redemption | $ | 251,758,580 | ||
Change in value of Class A common stock subject to possible redemption | $ | (770,672 | ) | |
Deferred underwriting fee payable | $ | 10,062,500 | ||
Initial classification of warrant liability | $ | 22,272,500 | ||
Offering costs by the Sponsor in exchange for the issuance of Class B common stock | $ | 25,000 | ||
Issuance of Class C common stock to Sponsor | $ | 575 | ||
As Previously Reported | Adjustments | As Restated | ||||||||||
Balance sheet as of December 10, 2020 (audited) | ||||||||||||
Total Liabilities | $ | 10,374,560 | $ | 22,272,500 | $ | 32,647,060 | ||||||
Warrant Liability | — | 22,272,500 | 22,272,500 | |||||||||
Class A Common Stock Subject to Possible Redemption | 274,031,080 | (22,272,500 | ) | 251,758,580 | ||||||||
Class A Common Stock | 135 | 222 | 357 | |||||||||
Additional Paid-in Capital | 4,999,913 | 879,809 | 5,879,722 | |||||||||
Accumulated Deficit | (999 | ) | (880,031 | ) | (881,030 | ) | ||||||
Total Stockholders’ Equity | 5,000,007 | — | 5,000,007 | |||||||||
Number of Class A common shares subject to redemption | 27,403,108 | (2,227,250 | ) | 25,175,858 | ||||||||
Balance sheet as of December 31, 2020 (audited) | ||||||||||||
Total Liabilities | $ | 10,168,977 | $ | 22,862,501 | $ | 33,031,478 | ||||||
Warrant Liability | — | 22,862,501 | 22,862,501 | |||||||||
Class A Common Stock Subject to Possible Redemption | 273,850,409 | (22,862,501 | ) | 250,987,908 | ||||||||
Class A Common Stock | 136 | 229 | 365 | |||||||||
Additional Paid-in Capital | 5,180,583 | 1,469,803 | 6,650,386 | |||||||||
Accumulated Deficit | (181,675 | ) | (1,470,032 | ) | (1,651,707 | ) | ||||||
Total Stockholders’ Equity | 5,000,002 | — | 5,000,002 | |||||||||
Number of Class A common shares subject to redemption | 27,385,874 | (2,287,083 | ) | 25,098,791 | ||||||||
Period from September 10, 2020 (inception) to December 31, 2020 (audited) | ||||||||||||
Net loss | $ | (181,675 | ) | $ | (1,470,032 | ) | $ | (1,651,707 | ) | |||
Weighted average shares outstanding, common stock subject to possible redemption | 27,403,108 | (2,227,250 | ) | 25,175,858 | ||||||||
Basic and diluted net earnings per share, common stock subject to possible redemption | 0.00 | — | 0.00 | |||||||||
Weighted average shares outstanding, non-redeemable common stock | 8,843,003 | 437,124 | 9,280,127 | |||||||||
Basic and diluted net loss per share, non-redeemable common stock | (0.02 | ) | (0.16 | ) | (0.18 | ) |
As Previously Reported | Adjustments | As Restated | ||||||||||
Cash Flow Statement for the Period from September 10, 2020 (inception) to December 31, 2020 (audited) | ||||||||||||
Net loss | $ | (181,675 | ) | $ | (1,470,032 | ) | $ | (1,651,707 | ) | |||
Allocation of initial public offering costs | — | 828,064 | 828,064 | |||||||||
Change in fair value of warrant liability | — | 590,001 | 590,001 | |||||||||
Compensation expense | — | 51,667 | 51,667 | |||||||||
Initial classification of warrant liability | — | 22,272,500 | 22,272,500 | |||||||||
Initial classification of common stock subject to possible redemption | 274,031,080 | (22,272,500 | ) | 251,758,580 | ||||||||
Change in value of common stock subject to possible redemption | (180,671 | ) | (590,001 | ) | (770,672 | ) |
For the Period from September 10, 2020 (Inception) through December 31, 2020 | ||||
Common stock subject to possible redemption | ||||
Numerator: Earnings allocable to Common stock subject to possible redemption | ||||
Interest earned on marketable securities held in Trust Account | $ | 7,355 | ||
Unrealized loss on marketable securities held in Trust Account | (15,686 | ) | ||
Less: Company’s portion available to pay taxes | — | |||
Net Loss allocable to shares subject to redemption | $ | (8,331 | ) | |
Denominator: Weighted Average Class A common stock subject to possible redemption | ||||
Basic and diluted weighted average shares outstanding | 25,175,858 | |||
Basic and diluted net loss per share | $ | 0.00 | ||
Non-Redeemable Common Stock | ||||
Numerator: Net Loss minus Net Earnings | ||||
Net loss | $ | (1,651,707 | ) | |
Add: Net loss allocable to Class A common stock subject to possible redemption | 8,331 | |||
Non-Redeemable Net Loss | $ | (1,643,376 | ) | |
Denominator: Weighted Average Non-Redeemable Common Stock | ||||
Basic and diluted weighted average shares outstanding | 9,280,127 | |||
Basic and diluted net loss per share | $ | (0.18 | ) | |
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
• | in whole and not in part; |
• | at a price of $0.01 per Public Warrant; |
• | upon not less than 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sale price of the Class A common stock for any 20-trading days within a30-trading day period ending on the third trading day prior to the date on which the Company send the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted). |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of our Class A common stock; |
• | if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted); and |
• | if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
December 31, 2020 | ||||
Deferred tax assets | ||||
Net operating loss carryforward | $ | 36,315 | ||
Unrealized loss on marketable securities held in Trust Account | 1,837 | |||
Total deferred tax assets | 38,152 | |||
Valuation Allowance | (38,152 | ) | ||
Deferred tax assets, net of allowance | $ | — | ||
As of December 31, 2020 | ||||
Federal | ||||
Current | $ | — | ||
Deferred | (38,152 | ) | ||
State and Local | ||||
Current | — | |||
Deferred | — | |||
Change in valuation allowance | 38,152 | |||
Income tax provision | $ | — | ||
December 31, 2020 | ||||
Statutory federal income tax rate | 21.0 | % | ||
State taxes, net of federal tax benefit | 0.0 | % | ||
Change in fair value of warrant liability | (18.7 | )% | ||
Valuation allowance | (2.3 | )% | ||
Income tax provision | 0.0 | % | ||
Description | Level | December 31, 2020 | ||||||
Assets: | ||||||||
Marketable securities held in Trust Account | 1 | $ | 287,491,254 | |||||
Liabilities: | ||||||||
Warrant Liability – Public Warrants | 3 | $ | 14,854,167 | |||||
Warrant Liability – Private Placement Warrants | 3 | $ | 8,008,334 |
Input | December 10, 2020 | December 31, 2020 | ||||||
Risk-free interest rate | 0.39 | % | 0.36 | % | ||||
Trading days per year | 252 | 252 | ||||||
Expected volatility | 29.0 | % | 29.0 | % | ||||
Exercise price | $ | 11.50 | $ | 11.50 | ||||
Stock Price | $ | 10.30 | $ | 10.41 |
Private Placement | Public | Warrant Liabilities | ||||||||||
Fair value as of September 10, 2020 (inception) | $ | — | $ | — | $ | — | ||||||
Initial measurement on December 10, 2020 | 7,801,667 | 14,470,833 | 22,272,500 | |||||||||
Change in valuation inputs or other assumptions | 206,667 | 383,334 | 590,001 | |||||||||
Fair value as of December 31, 2020 | $ | 8,008,334 | $ | 14,854,167 | $ | 22,862,501 | ||||||
June 30, 2021 | December 31, 2020 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Current Assets | ||||||||
Cash and cash equivalents | $ | 123,871 | $ | 780,292 | ||||
Prepaid expenses | 365,366 | 747,842 | ||||||
Total Current Assets | 489,237 | 1,528,134 | ||||||
Cash and marketable securities held in Trust Account | 287,538,614 | 287,491,254 | ||||||
TOTAL ASSETS | $ | 288,027,851 | $ | 289,019,388 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||
Accounts payable and accrued expenses | $ | 3,053,408 | $ | 106,477 | ||||
Promissory note - related party | 500,000 | — | ||||||
Total Current Liabilities | 3,553,408 | 106,477 | ||||||
Warrant liability | 29,603,334 | 22,862,501 | ||||||
Deferred underwriting fee payable | 10,062,500 | 10,062,500 | ||||||
Total Liabilities | 43,219,242 | 33,031,478 | ||||||
Commitments | ||||||||
Class A common stock subject to possible redemption 28,750,000 and 25,098,791 shares at redemption value at June 30, 2021 and December 31, 2020, respectively | 287,500,000 | 250,987,908 | ||||||
Stockholders’ Equity (Deficit) | ||||||||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding | — | — | ||||||
Class A common stock, $0.0001 par value; 75,000,000 shares authorized; 0 and 3,651,209 issued and outstanding (excluding 28,750,000 and 25,098,791 shares subject to possible redemption) at June 30, 2021 and December 31, 2020, respectively | — | 365 | ||||||
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 3,833,333 shares issued and outstanding | 383 | 383 | ||||||
Class C common stock, $0.0001 par value; 15,000,000 shares authorized; 5,750,000 shares issued and outstanding | 575 | 575 | ||||||
Additional paid-in capital | 24,138 | 6,650,386 | ||||||
Accumulated deficit | (42,716,487 | ) | (1,651,707 | ) | ||||
Total Stockholders’ Equity (Deficit) | (42,691,391 | ) | 5,000,002 | |||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | $ | 288,027,851 | $ | 289,019,388 | ||||
Three Months Ended June 30, 2021 | Six Months Ended June 30, 2021 | |||||||
Formation and operating costs | $ | 1,157,655 | $ | 4,485,844 | ||||
Loss from operations | (1,157,655 | ) | (4,485,844 | ) | ||||
Other expense: | ||||||||
Change in fair value of derivative liabilities | (398,333 | ) | (6,740,833 | ) | ||||
Interest income - bank | 2 | 16 | ||||||
Interest earned on marketable securities held in Trust Account | 4,614 | 47,360 | ||||||
Unrealized loss on marketable securities held in Trust Account | (744 | ) | — | |||||
Other expense, net | (394,461 | ) | (6,693,457 | ) | ||||
Loss before income taxes | (1,552,116 | ) | (11,179,301 | ) | ||||
Provision for income taxes | — | — | ||||||
Net loss | $ | (1,552,116 | ) | $ | (11,179,301 | ) | ||
Basic and diluted weighted average shares outstanding, Class A common stock subject to redemption | 28,750,000 | 27,674,922 | ||||||
Basic and diluted net income per share, Class A common stock subject to redemption | $ | 0.00 | $ | 0.00 | ||||
Basic and diluted weighted average shares outstanding, Non-redeemable common stock | 9,583,333 | 10,658,411 | ||||||
Basic and diluted net loss per share, Non-redeemable common stock | $ | (0.16 | ) | $ | (1.05 | ) | ||
Class A Common Stock | Class B Common Stock | Class C Common Stock | Additional Paid-in | Accumulated | Total Stockholders’ | |||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Shares | Amount | Capital | Deficit | Equity (Deficit) | ||||||||||||||||||||||||||||
Balance – December 31, 2020 | 3,651,209 | $ | 365 | 3,833,333 | $ | 383 | 5,750,000 | $ | 575 | $ | 6,650,386 | $ | (1,651,707 | ) | $ | 5,000,002 | ||||||||||||||||||||
Change in fair value of common stock subject to possible redemption | (3,651,209 | ) | (365 | ) | — | — | — | — | (6,626,248 | ) | (29,885,479 | ) | (36,512,092 | ) | ||||||||||||||||||||||
Net loss | — | — | — | — | — | — | — | (9,627,185 | ) | (9,627,185 | ) | |||||||||||||||||||||||||
Balance – March 31, 2021 | — | $ | — | 3,833,333 | $ | 383 | 5,750,000 | $ | 575 | $ | 24,138 | $ | (41,164,371 | ) | $ | (41,139,275 | ) | |||||||||||||||||||
Net loss | — | — | — | — | — | — | — | (1,552,116 | ) | (1,552,116 | ) | |||||||||||||||||||||||||
Balance – June 30, 2021 | — | $ | — | 3,833,333 | $ | 383 | 5,750,000 | $ | 575 | $ | 24,138 | $ | (42,716,487 | ) | $ | (42,691,391 | ) | |||||||||||||||||||
Cash Flows from Operating Activities: | ||||
Net loss | $ | (11,179,301 | ) | |
Adjustments to reconcile net income to net cash used in operating activities: | ||||
Interest earned on marketable securities held in Trust Account | (47,360 | ) | ||
Change in fair value of derivative liabilities | 6,740,833 | |||
Changes in operating assets and liabilities: | ||||
Prepaid expenses | 382,476 | |||
Accounts payable and accrued expenses | 2,946,931 | |||
Net cash used in operating activities | (1,156,421 | ) | ||
Cash Flows from Financing Activities: | ||||
Proceeds from promissory note – related party | 500,000 | |||
Net cash provided by financing activities | 500,000 | |||
Net Change in Cash and Cash Equivalents | (656,421 | ) | ||
Cash and Cash Equivalents – Beginning of period | 780,292 | |||
Cash and Cash Equivalents – End of period | $ | 123,871 | ||
Non-Cash investing and financing activities: | ||||
Change in value of Class A common stock subject to possible redemption | $ | 36,512,092 | ||
Three Months Ended June 30, 2021 | Six Months Ended June 30, 2021 | |||||||
Class A common stock subject to possible redemption | ||||||||
Numerator: Earnings allocable to Common stock subject to possible redemption | ||||||||
Interest earned on marketable securities held in Trust Account | $ | 4,614 | $ | (47,360 | ) | |||
Unrealized loss on marketable securities held in Trust Account | (744 | ) | — | |||||
Less: Company’s portion available to pay taxes | (3,870 | ) | (47,360 | ) | ||||
Net Income allocable to shares subject to redemption | $ | — | $ | — | ||||
Denominator: Weighted Average Class A common stock subject to possible redemption | ||||||||
Basic and diluted weighted average shares outstanding | 28,750,000 | 27,674,922 | ||||||
Basic and diluted net income per share | $ | 0.00 | $ | 0.00 | ||||
Non-Redeemable Common Stock | ||||||||
Numerator: Net Loss minus Net Earnings | ||||||||
Net loss | $ | (1,552,116 | ) | $ | (11,179,301 | ) | ||
Non-Redeemable Net Loss | $ | (1,552,116 | ) | $ | (11,179,301 | ) | ||
Denominator: Weighted Average Non-redeemable Common stock | ||||||||
Basic and diluted weighted average shares outstanding | 9,583,333 | 10,658,411 | ||||||
Basic and diluted net loss per share | $ | (0.16 | ) | $ | (1.05 | ) | ||
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
• | in whole and not in part; |
• | at a price of $0.01 per Public Warrant; |
• | upon not less than 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the last reported sale price of the Class A common stock for any 20-trading days within a30-trading day period ending on the third trading day prior to the date on which the Company send the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted). |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of our Class A common stock; |
• | if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted); and |
• | if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
Description | Level | June 30, 2021 | December 31, 2020 | |||||||||
Assets: | ||||||||||||
Marketable securities held in Trust Account | 1 | $ | 287,538,614 | $ | 287,491,254 | |||||||
Liabilities: | ||||||||||||
Warrant Liability – Public Warrants | 1 | $ | 19,166,666 | $ | 14,854,167 | |||||||
Warrant Liability – Private Placement Warrants | 2 | $ | 10,436,667 | $ | 8,008,334 |
Input | June 30, 2021 | December 31, 2020 | ||||||
Risk-free interest rate | 0.87 | % | 0.36 | % | ||||
Trading days per year | 252 | |||||||
Expected volatility | 27.50 | % | 29.0 | % | ||||
Expected Term (in years) | 5 | 5 | ||||||
Exercise price | $ | 11.50 | $ | 11.50 | ||||
Stock Price | $ | 9.97 | $ | 10.41 |
Private Placement | Public | Warrant Liabilities | ||||||||||
Fair value as of December 31, 2020 | $ | 8,008,334 | $ | 14,854,166 | $ | 22,862,500 | ||||||
Change in valuation inputs or other assumptions | 2,428,333 | 4,312,500 | 6,740,833 | |||||||||
Fair value as of June 30, 2021 | $ | 10,436,667 | $ | 19,166,666 | $ | 29,603,333 | ||||||
Item 13. | Other Expenses of Issuance and Distribution. |
SEC Filing Fee | $208,588.75 | |||
FINRA Filing Fee | * | |||
Printing Expenses | * | |||
Legal Fees and Expenses | * | |||
Accounting Fees and Expenses | * | |||
Transfer Agent and Registrar Fees | * | |||
Miscellaneous | * | |||
Total | $ | * | ||
* | To be filed by amendment. |
Item 14. | Indemnification of Directors and Officers. |
Item 15. | Recent Sales of Unregistered Securities. |
• | On December 10, 2020, RAAC issued 5,166,667 Private Placement Warrants to RAAC’s sponsor, RAAC Management LLC, concurrently with the closing of RAAC’s initial public offering; and |
• | On July 21, 2021, we issued 16,500,000 shares of our Class A common stock to certain qualified institutional buyers and accredited investors that agreed to purchase such shares in connection with the Business Combination for aggregate consideration of $165,000,000. |
Item 16. | Exhibits and Financial Statements Schedules. |
Exhibit Number | Description | |
21.1 | List of Subsidiaries (incorporated by reference to Exhibit 21.1 to the Registrant’s Current Report on Form 8-K (File No. 001-39768) filed on July 27, 2021). | |
23.1 | Consent of Marcum LLP, independent registered public accounting firm of RAAC. | |
23.2 | Consent of Grant Thornton LLP, independent registered public accounting firm of Berkshire Grey, Inc. | |
23.3* | Consent of Goodwin Procter LLP (included in Exhibit 5.1 hereto). | |
24.1 | Power of Attorney (included on signature page hereto). | |
101.INS | Inline XBRL Instance Document | |
101.SCH | Inline XBRL Taxonomy Extension Schema Document | |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
+ | Schedules omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request. |
* | To be filed by amendment. |
Item 17. | Undertakings. |
(1) | to file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |
(2) | that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; |
(3) | to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering; |
(4) | that, for the purpose of determining liability under the Securities Act to any purchaser: |
(5) | that, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: |
BERKSHIRE GREY, INC. | ||
By: | /s/ Thomas Wagner | |
Name: | Thomas Wagner | |
Title: | Chief Executive Officer |
Signature | Title | Date | ||
/s/ Thomas Wagner Thomas Wagner | Chief Executive Officer and Director (principal executive officer) | August 20, 2021 | ||
/s/ Mark Fidler Mark Fidler | Chief Financial Officer (principal financial officer and principal accounting officer) | August 20, 2021 | ||
/s/ Peter Barris Peter Barris | Director | August 20, 2021 | ||
/s/ John K. Delaney John K. Delaney | Director | August 20, 2021 | ||
/s/ Fiona P. Dias Fiona P. Dias | Director | August 20, 2021 | ||
/s/ Sven Strohband Sven Strohband | Director | August 20, 2021 | ||
/s/ Serena Wolfe Serena Wolfe | Director | August 20, 2021 |